match no. | target id | target length | alignment length | probability | E-value | coverage | match description |
1 | 4YFI_A | 330 | 251 | 100.0 | 6E-38 | [------------ ] | TNNI3K (E.C.2.7.11.1); kinase, Transferase-Transferase Inhibitor complex; HET: 4CW; 2.7A {Homo sapiens} |
2 | 4IDV_D | 356 | 250 | 100.0 | 7.5E-38 | [------------ ] | Mitogen-activated protein kinase kinase kinase; NIK, Nuclear factor (NF)-kB, p100; HET: 13V; 2.9A {Homo sapiens} |
3 | 2Y7J_A | 365 | 245 | 100.0 | 2E-37 | [----------- ] | PHOSPHORYLASE B KINASE GAMMA CATALYTIC; TRANSFERASE; HET: B49; 2.5A {HOMO SAPIENS} |
4 | 2PSQ_A | 370 | 251 | 100.0 | 4.4E-37 | [------------ ] | Fibroblast growth factor receptor 2; Kinase Domain Fold Consisting of; HET: SO4; 2.4A {Homo sapiens} SCOP: d.144.1.7 |
5 | 5TE0_A | 347 | 248 | 100.0 | 1.8E-37 | [----------- ] | BMP-2-inducible protein kinase (E.C.2.7.11.1); transferase, protein kinase domain, Structural; HET: XIN, GOL; 1.9A {Homo sapiens} |
6 | 4PF4_A | 278 | 248 | 100.0 | 2.6E-37 | [----------- ] | DEATH-ASSOCIATED PROTEIN KINASE 1 ; TRANSFERASE; HET: GOL, SO4; 1.13A {Homo sapiens} |
7 | 4G3F_A | 336 | 252 | 100.0 | 6.8E-38 | [------------ ] | NF-kappa-beta-inducing kinase (E.C.2.7.11.25); non-RD kinase, protein serine/threonine kinase; HET: 0WB; 1.642A {Mus musculus} |
8 | 5J0A_B | 304 | 259 | 100.0 | 6.2E-37 | [------------ ] | Lymphokine-activated killer T-cell-originated protein kinase; Protein kinase, TRANSFERASE; HET: HC4, SO4; 2.74A {Homo sapiens} |
9 | 2WEL_A | 327 | 245 | 100.0 | 1.5E-36 | [----------- ] | CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II; CELLULAR DIFFERENTIATION, SERINE/THREONINE-PROTEIN KINASE, PHOSPHOPROTEIN; HET: K88, EDO, PO4; 1.9A {HOMO SAPIENS} |
10 | 4NIF_D | 333 | 252 | 100.0 | 1.2E-36 | [------------ ] | Ribosomal protein S6 kinase alpha-1; Kinase domain, SIGNALING, Substrate kinase; HET: ANP, SO4; 2.15A {Homo sapiens} |
11 | 3ZZW_A | 289 | 250 | 100.0 | 2.1E-36 | [------------ ] | TYROSINE-PROTEIN KINASE TRANSMEMBRANE RECEPTOR ROR2; TRANSFERASE, NEUROTROPHIC TYROSINE KINASE, RECEPTOR-RELATED; HET: SO4; 2.9A {HOMO SAPIENS} |
12 | 4AT5_A | 299 | 248 | 100.0 | 2.8E-36 | [------------ ] | BDNF/NT-3 GROWTH FACTORS RECEPTOR (E.C.2.7.10.1); TRANSFERASE; HET: MUJ; 1.71A {HOMO SAPIENS} |
13 | 3C0I_A | 351 | 248 | 100.0 | 8.8E-37 | [----------- ] | Peripheral plasma membrane protein CASK; CASK, neurexin, Ca2+/calmodulin dependent protein; HET: 3AM; 1.85A {Homo sapiens} |
14 | 5IU2_B | 332 | 241 | 100.0 | 1.8E-36 | [------------ ] | Mitogen-activated protein kinase kinase kinase; COT, Tpl-2, MAP3K8, kinase, inhibitor; HET: 6DA; 2.7A {Homo sapiens} |
15 | 4Y85_A | 332 | 242 | 100.0 | 2E-36 | [------------ ] | Mitogen-activated protein kinase kinase kinase; COT, Tpl-2, MAP3K8, kinase, inhibitor; HET: 499; 2.33A {Homo sapiens} |
16 | 5UIT_A | 323 | 254 | 100.0 | 5.2E-36 | [------------ ] | Interleukin-1 receptor-associated kinase 4 (E.C.2.7.11.1); IRAK4, Kinase, TRANSFERASE; HET: SEP, TPO, 8CD; 1.84A {Homo sapiens} |
17 | 5HU9_A | 277 | 247 | 100.0 | 2.8E-36 | [------------ ] | Serine/threonine-protein kinase 3 (E.C.2.7.11.1); Abl, BCR-Abl, CHMFL-074, TRANSFERASE-TRANSFERASE INHIBITOR; HET: EDO, 66K; 1.529A {Homo sapiens} |
18 | 5NG3_A | 304 | 261 | 100.0 | 9E-37 | [------------ ] | Receptor-interacting serine/threonine-protein kinase 2 (E.C.2.7.11.1,2.7.10.2); RIP2K, Kinase, Inactive state, HelixC-OUT; HET: TPO, SO4; 2.6A {Homo sapiens} |
19 | 2PHK_A | 277 | 244 | 100.0 | 4.1E-36 | [----------- ] | PHOSPHORYLASE KINASE, MC-PEPTIDE, ADENOSINE-5'-TRIPHOSPHATE; CATALYTIC MECHANISM, DIMERIZATION, PHOSPHORYLASE KINASE; HET: ATP; 2.6A {Oryctolagus cuniculus} SCOP: d.144.1.7 |
20 | 4ZSL_A | 341 | 257 | 100.0 | 9.6E-36 | [------------ ] | Mitogen-activated protein kinase 7 (E.C.2.7.11.24); KINASE, INHIBITOR, transferase; HET: GOL, 4QZ; 2.25A {Homo sapiens} |
21 | 4ASE_A | 353 | 250 | 100.0 | 1.8E-36 | [------------ ] | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; TRANSFERASE, ANGIOGENESIS, SIGNALING PROTEIN, PHOSPHORYLATION; HET: AV9; 1.83A {HOMO SAPIENS} |
22 | 3C0G_B | 351 | 248 | 100.0 | 1.3E-36 | [----------- ] | Peripheral plasma membrane protein CASK; CASK, neurexin, Ca2+/calmodulin dependent protein; HET: 3AM; 2.19A {Homo sapiens} |
23 | 5IG1_B | 344 | 254 | 100.0 | 6E-36 | [------------ ] | CAMK/CAMK2 protein kinase; Ca2+/CaM-dependent kinase, choanoflagellate, TRANSFERASE; HET: PO4; 2.9A {Salpingoeca rosetta} |
24 | 4JXF_A | 266 | 240 | 100.0 | 1.7E-36 | [----------- ] | Serine/threonine-protein kinase PLK4 (E.C.2.7.11.21); Serine/Threonine kinase, Polo-like kinase 4; HET: 631; 2.4A {Homo sapiens} |
25 | 1UVR_A | 289 | 250 | 100.0 | 3.7E-36 | [------------ ] | 3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1 (E.C.2.7.1.37); PROTEIN KINASE, PKB, PDK1, INHIBITOR; HET: GOL, BI8, SO4; 2.81A {HOMO SAPIENS} SCOP: d.144.1.7 |
26 | 3F3Z_A | 277 | 243 | 100.0 | 5.8E-36 | [----------- ] | kinase; calcium dependent protein kinase, structural; HET: DRK, GOL; 1.84A {Cryptosporidium parvum Iowa II} |
27 | 4J53_A | 293 | 254 | 100.0 | 1.2E-35 | [------------ ] | Serine/threonine-protein kinase PLK1 (E.C.2.7.11.21); protein serine/threonine kinase, mitosis, oncogenesis; HET: 1J4; 2.5A {Homo sapiens} |
28 | 2QOC_A | 344 | 252 | 100.0 | 4.3E-36 | [------------ ] | Ephrin receptor (E.C.2.7.10.1); receptor tyrosine kinase, structural genomics; HET: ANP; 1.25A {Homo sapiens} |
29 | 4IXP_A | 348 | 252 | 100.0 | 2.4E-36 | [------------ ] | Maternal embryonic leucine zipper kinase; protein kinase, regulated by phosphorylation; 2.749A {Homo sapiens} |
30 | 3KK8_A | 284 | 253 | 100.0 | 9.2E-36 | [------------ ] | Calcium/calmodulin dependent protein kinase II; Protein Kinase, ATP-binding, Kinase, Nucleotide-binding; 1.72A {Caenorhabditis elegans} |
31 | 5NG0_A | 304 | 261 | 100.0 | 1.1E-35 | [------------ ] | Receptor-interacting serine/threonine-protein kinase 2 (E.C.2.7.11.1,2.7.10.2); RIP2K, Kinase, Active state, AMPPCPP; HET: ACP; 2.0A {Homo sapiens} |
32 | 2X4F_A | 373 | 242 | 100.0 | 4E-36 | [----------- ] | MYOSIN LIGHT CHAIN KINASE FAMILY; LUNG, KINASE, MYOSIN, BREAST CANCER; HET: 1PE, 16X, EDO; 2.67A {HOMO SAPIENS} |
33 | 3RP9_A | 458 | 259 | 100.0 | 2E-35 | [------------ ] | Mitogen-activated protein kinase (E.C.2.7.11.24); Structural Genomics, Structural Genomics Consortium; 2.4A {Toxoplasma gondii} |
34 | 2BDW_B | 362 | 246 | 100.0 | 1.4E-35 | [----------- ] | Hypothetical protein K11E8.1d; kinase calmodulin activated, TRANSFERASE; 1.8A {Caenorhabditis elegans} |
35 | 4ASZ_A | 299 | 248 | 100.0 | 5.1E-36 | [------------ ] | BDNF/NT-3 GROWTH FACTORS RECEPTOR (E.C.2.7.10.1); TRANSFERASE, TRKA, TRKB; 1.7A {HOMO SAPIENS} |
36 | 4HZR_B | 277 | 255 | 100.0 | 8.3E-36 | [------------ ] | Activated CDC42 kinase 1 (E.C.2.7.10.2; active state, phosphotransfer, TRANSFERASE; HET: SO4; 1.31A {Homo sapiens} |
37 | 3BKB_A | 377 | 247 | 100.0 | 3.2E-36 | [------------ ] | Proto-oncogene tyrosine-protein kinase Fes/Fps (E.C.2.7.10.2); FES, v-fes, Fujinami, avian sarcoma; HET: EDO, STU, SO4; 1.78A {Homo sapiens} |
38 | 4F1M_A | 287 | 250 | 100.0 | 4.3E-36 | [------------ ] | Serine/threonine-protein kinase roco4 (E.C.2.7.11.1); Protein Kinase, LRRK2, ROCO, Kinase; HET: BTB, ACP; 2.04A {Dictyostelium discoideum} |
39 | 4EWH_A | 275 | 253 | 100.0 | 8.6E-36 | [------------ ] | Activated CDC42 kinase 1 (E.C.2.7.10.2; Drug Design, Enzyme Inhibitors, TRANSFERASE-TRANSFERASE; HET: T77; 2.5A {Homo sapiens} |
40 | 5VLO_A | 302 | 245 | 100.0 | 1.3E-35 | [----------- ] | Calcium/calmodulin-dependent protein kinase type II; Kinase, CamKII, inhibitor, TRANSFERASE; HET: DTT, 9EJ; 2.05A {Homo sapiens} |
41 | 5VCZ_A | 311 | 238 | 100.0 | 6.1E-36 | [----------- ] | Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory; KINASE DOMAIN, CELL CYCLE, TYROSINE-; HET: EDO, PEG, XZN; 1.5A {Homo sapiens} |
42 | 5VCY_A | 311 | 238 | 100.0 | 6.1E-36 | [----------- ] | Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory; KINASE DOMAIN, CELL CYCLE, TYROSINE-; HET: DB8, EDO, PEG, DMS; 1.56A {Homo sapiens} |
43 | 3DTC_A | 271 | 250 | 100.0 | 1.3E-35 | [------------ ] | Mitogen-activated protein kinase kinase kinase; mixed-lineage kinase, MLK family, MLK1; HET: VIN; 2.6A {Homo sapiens} |
44 | 1YVJ_A | 290 | 252 | 100.0 | 9.9E-36 | [------------ ] | Tyrosine-protein kinase JAK3 (E.C.2.7.1.112); TYROSINE KINASE SCID ; HET: DTV, 4ST; 2.55A {Homo sapiens} |
45 | 5AMN_A | 299 | 250 | 100.0 | 1.7E-35 | [------------ ] | PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET; TRANSFERASE, RET, ONCOGENE, RECEPTOR TYROSINE; HET: DTQ, FMT, PTR; 2.57A {HOMO SAPIENS} |
46 | 4F0I_B | 300 | 251 | 100.0 | 1.2E-35 | [------------ ] | High affinity nerve growth factor; Tyrosine Kinase, Rossmann Fold, TRANSFERASE; 2.302A {Homo sapiens} |
47 | 5A46_B | 386 | 256 | 100.0 | 3.5E-35 | [------------ ] | FIBROBLAST GROWTH FACTOR RECEPTOR 1; TRANSFERASE, KINASE; HET: SO4, EDO, 38O; 2.63A {HOMO SAPIENS} |
48 | 4TWC_B | 295 | 259 | 100.0 | 4.4E-36 | [------------ ] | Casein kinase 1 delta (E.C.2.7.11.1); CK1d, CK1e, Phosphorylation, Small molecule; HET: BOG, 37J, GOL, SO4; 1.7A {Homo sapiens} |
49 | 2VN9_A | 301 | 245 | 100.0 | 3.7E-35 | [----------- ] | CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II; SERINE/THREONINE-PROTEIN KINASE, SERINE-THREONINE KINASE, CELLULAR; HET: PO4, EPE, GVD; 2.3A {HOMO SAPIENS} |
50 | 1TKI_B | 321 | 242 | 100.0 | 9.6E-36 | [----------- ] | TITIN; SERINE KINASE, TITIN, MUSCLE, AUTOINHIBITION; 2.0A {Homo sapiens} SCOP: d.144.1.7 |
51 | 2QOL_A | 373 | 252 | 100.0 | 1.3E-35 | [------------ ] | Ephrin receptor (E.C.2.7.10.1); receptor tyrosine kinase, juxtamembrane segment; 1.07A {Homo sapiens} |
52 | 4JS8_A | 281 | 245 | 100.0 | 2.9E-35 | [----------- ] | Dual specificity protein kinase TTK; Transferase-Transferase Inhibitor complex; HET: SO4, GOL, PEG, 1PF; 1.94A {Homo sapiens} |
53 | 3CBL_A | 377 | 247 | 100.0 | 4.4E-36 | [------------ ] | Proto-oncogene tyrosine-protein kinase Fes/Fps (E.C.2.7.10.2); FES, v-fes, Fujinami, avian sarcoma; HET: STU; 1.75A {Homo sapiens} |
54 | 4B6L_A | 281 | 252 | 100.0 | 4.7E-35 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE PLK3 (E.C.2.7.11.21); TRANSFERASE, KINASE INHIBITORS, WATER-MEDIATED H-BOND; HET: 9ZP; 1.9A {HOMO SAPIENS} |
55 | 4TWC_A | 295 | 259 | 100.0 | 4.4E-36 | [------------ ] | Casein kinase 1 delta (E.C.2.7.11.1); CK1d, CK1e, Phosphorylation, Small molecule; HET: 37J, BOG, GOL, SO4; 1.7A {Homo sapiens} |
56 | 4PDP_B | 347 | 252 | 100.0 | 1.1E-36 | [------------ ] | Serine/threonine-protein kinase RAD53 (E.C.2.7.12.1); Ser/Thr kinase domain, N-lobe, C-lobe; 2.591A {Saccharomyces cerevisiae} |
57 | 3OY3_B | 284 | 247 | 100.0 | 7.6E-36 | [------------ ] | Tyrosine-protein kinase ABL1 (E.C.2.7.10.2); Protein-inhibitor complex, Protein kinase two-domain; HET: XY3; 1.95A {Mus musculus} |
58 | 2WQM_A | 310 | 251 | 100.0 | 1.7E-35 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE NEK7 (E.C.2.7.11.1); ATP-BINDING, METAL-BINDING, SERINE/THREONINE-PROTEIN KINASE, CELL; 2.1A {HOMO SAPIENS} |
59 | 5FTO_A | 315 | 254 | 100.0 | 1.8E-35 | [------------ ] | ALK TYROSINE KINASE RECEPTOR (E.C.2.7.10.1); TRANSFERASE, KINASE INHIBITORS, CANCER, DRUG; HET: YMX; 2.22A {HOMO SAPIENS} |
60 | 2JII_B | 352 | 264 | 100.0 | 1.6E-35 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE VRK3 MOLECULE: VACCINIA; TRANSFERASE, PSEUDO KINASE DOMAIN, VACCINIA; HET: EDO; 2.0A {HOMO SAPIENS} |
61 | 2QR8_A | 342 | 256 | 100.0 | 2.2E-35 | [------------ ] | Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding; 2.0A {Mus musculus} |
62 | 5M08_B | 276 | 228 | 100.0 | 6.6E-36 | [----------- ] | Serine/threonine-protein kinase PknI (E.C.2.7.11.1); Tuberculosis, kinase, signalling, signaling protein; 3.03A {Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)} |
63 | 5BYZ_A | 348 | 249 | 100.0 | 5.7E-35 | [----------- ] | Mitogen-activated protein kinase 7 (E.C.2.7.11.24); ERk5, kinase inhibitor, transferase; HET: 4WE, GOL; 1.65A {Homo sapiens} |
64 | 5NKH_A | 306 | 252 | 100.0 | 1.1E-34 | [------------ ] | Ephrin type-A receptor 2 (E.C.2.7.10.1); Inhibitor, Complex, Protein Tyrosine Kinase; HET: 8ZQ; 1.29A {Homo sapiens} |
65 | 5T6A_A | 525 | 245 | 100.0 | 2.6E-35 | [----------- ] | Calmodulin-domain protein kinase 1; Structural Genomics Consortium, SGC, CDPKs; HET: 5GA; 2.05A {Toxoplasma gondii} |
66 | 2CMW_A | 310 | 263 | 100.0 | 1.6E-35 | [------------ ] | CASEIN KINASE I ISOFORM GAMMA-1; WNT SIGNALING PATHWAY, SERINE/THREONINE-PROTEIN KINASE; HET: OLP; 1.75A {HOMO SAPIENS} |
67 | 3DAK_D | 290 | 249 | 100.0 | 1.6E-35 | [----------- ] | Serine/threonine-protein kinase OSR1; SERINE/THREONINE PROTEIN KINASE, STE20, DOMAIN-SWAPPING; HET: ANP; 2.25A {Homo sapiens} |
68 | 5NTT_A | 287 | 245 | 100.0 | 8.6E-35 | [----------- ] | Dual specificity protein kinase TTK; Mps1, TTK, kinase, inhibitor, NMS-P715; HET: SVE, TPO; 2.75A {Homo sapiens} |
69 | 2R2P_A | 295 | 251 | 100.0 | 4.4E-35 | [------------ ] | Ephrin type-A receptor 5 (E.C.2.7.10.1); ATP-BINDING, KINASE, NUCLEOTIDE-BINDING, RECEPTOR, TRANSFERASE; HET: SO4; 2.4A {Homo sapiens} |
70 | 4Y95_C | 266 | 245 | 100.0 | 3.4E-35 | [------------ ] | Btk kinase domain (E.C.2.7.10.2); Btk, kinase domain, TRANSFERASE; HET: GOL, BME, PE4, 746; 1.599A {Bos taurus} |
71 | 2W4O_A | 349 | 250 | 100.0 | 3.1E-35 | [------------ ] | CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE IV; CALMODULIN-BINDING, NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING; HET: DKI; 2.17A {HOMO SAPIENS} |
72 | 4CKJ_A | 314 | 249 | 100.0 | 2.4E-35 | [------------ ] | PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET; TRANSFERASE; HET: ADN, FMT; 1.65A {HOMO SAPIENS} |
73 | 4AZF_A | 417 | 245 | 100.0 | 3.4E-35 | [------------ ] | DYRK2 DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REGULATED KINASE; TRANSFERASE; HET: 3RA; 2.55A {HOMO SAPIENS} |
74 | 3KFA_A | 288 | 248 | 100.0 | 6E-35 | [------------ ] | Tyrosine-protein kinase transforming protein Abl; Abl, CML, drug resistance, inhibitor; HET: B91; 1.22A {Mus musculus} |
75 | 3TT0_A | 382 | 253 | 100.0 | 8E-35 | [------------ ] | Basic fibroblast growth factor receptor; kinase domain, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR; HET: 07J, GOL, SO4; 2.8A {Homo sapiens} |
76 | 2H6D_A | 276 | 240 | 100.0 | 1.9E-35 | [----------- ] | 5'-AMP-activated protein kinase catalytic subunit; ATP-binding Cholesterol biosynthesis ; 1.85A {Homo sapiens} |
77 | 5LXC_B | 408 | 250 | 100.0 | 3E-35 | [------------ ] | Dual specificity tyrosine-phosphorylation-regulated kinase 2; Transferase, kinase, inhibitor, unusual binding; HET: PTR, EDO, 7AA; 2.15A {Homo sapiens} |
78 | 1U5Q_B | 348 | 251 | 100.0 | 2.5E-35 | [------------ ] | serine/threonine protein kinase TAO2; serine/threonine protein kinase, TRANSFERASE; 2.1A {Rattus norvegicus} SCOP: d.144.1.7 |
79 | 2RKU_A | 294 | 247 | 100.0 | 9.7E-35 | [------------ ] | Serine/threonine-protein kinase PLK1 (E.C.2.7.11.21); Structure of PLK1, selectivity residues; HET: R78, TLA, SRT, TAR; 1.95A {Homo sapiens} |
80 | 4YNZ_B | 342 | 252 | 100.0 | 2.5E-35 | [------------ ] | Serine/threonine-protein kinase BRSK2 (E.C.2.7.11.26); kinase domain, UBA domain, TRANSFERASE; 2.0A {Mus musculus} |
81 | 5K00_A | 335 | 240 | 100.0 | 1.6E-35 | [----------- ] | Maternal embryonic leucine zipper kinase; kinase UBA typeII inhibitor, TRANSFERASE-TRANSFERASE; HET: 6PV; 1.77A {Homo sapiens} |
82 | 4HCU_A | 269 | 244 | 100.0 | 7.8E-35 | [------------ ] | Tyrosine-protein kinase ITK/TSK (E.C.2.7.10.2); kinase, transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} |
83 | 2Y4I_B | 319 | 253 | 100.0 | 2.1E-34 | [------------ ] | KINASE SUPPRESSOR OF RAS 2; TRANSFERASE, KSR1; HET: ATP; 3.46A {HOMO SAPIENS} |
84 | 4RGJ_A | 520 | 252 | 100.0 | 2.6E-35 | [------------ ] | Calcium-dependent protein kinase 4 (E.C.2.7.11.1); structural genomics, Structural Genomics Consortium; 2.303A {Plasmodium falciparum} |
85 | 4H58_C | 275 | 252 | 100.0 | 4.7E-35 | [------------ ] | Serine/threonine-protein kinase B-raf (E.C.2.7.11.1); protein kinase, structure based drug; HET: 10Z; 3.1A {Homo sapiens} |
86 | 5HHW_A | 307 | 250 | 100.0 | 7.2E-35 | [------------ ] | Insulin receptor (E.C.2.7.10.1); Inhibitor, Complex, Insulin receptor, Kinase; HET: 60O; 1.79A {Homo sapiens} |
87 | 5FQD_F | 341 | 259 | 100.0 | 1.8E-35 | [------------ ] | DNA DAMAGE-BINDING PROTEIN 1 (E.C.6.3.2.19); LIGASE, DNA BINDING; HET: LVY; 2.45A {HOMO SAPIENS} |
88 | 5JGA_A | 315 | 241 | 100.0 | 4.4E-35 | [------------ ] | Mitogen-activated protein kinase kinase kinase; Transferase-Transferase inhibitor complex, TAK1-TAB1 kinase; HET: 6KC; 2.0A {Homo sapiens} |
89 | 4KNB_A | 287 | 251 | 100.0 | 6.7E-35 | [------------ ] | Hepatocyte growth factor receptor (E.C.2.7.10.1); protein kinase, TRANSFERASE; HET: 1RU, GBL; 2.4A {Homo sapiens} |
90 | 2Y6O_A | 291 | 252 | 100.0 | 6.8E-35 | [------------ ] | EPHRIN TYPE-A RECEPTOR 4 (E.C.2.7.10.1); SIGNALLING PROTEIN, TRANSFERASE; HET: 1N1; 1.543A {MUS MUSCULUS} |
91 | 1KOB_A | 387 | 251 | 100.0 | 3.7E-35 | [------------ ] | TWITCHIN, VALINE; KINASE, TWITCHIN, INTRASTERIC REGULATION; 2.3A {Aplysia californica} SCOP: d.144.1.7 |
92 | 4BGQ_A | 304 | 247 | 100.0 | 4.6E-35 | [----------- ] | CYCLIN-DEPENDENT KINASE-LIKE 5 (E.C.2.7.11.22); TRANSFERASE, PHOSPHO-MIMETIC, KINASE; HET: 38R; 2.0A {HOMO SAPIENS} |
93 | 4QNY_B | 354 | 272 | 100.0 | 2E-34 | [------------- ] | Mitogen activated protein kinase, putative; Structural Genomics, Structural Genomics Consortium; HET: ANP; 2.257A {Leishmania donovani} |
94 | 4XBR_A | 366 | 246 | 100.0 | 4.5E-35 | [------------ ] | Protein FAM212A,Serine/threonine-protein kinase PAK 4(E.C.2.7.11.1); PAK4, Inka, Crystallization, Transferase; HET: SEP, ATP; 2.94A {Homo sapiens} |
95 | 1YRP_B | 278 | 247 | 100.0 | 4.4E-35 | [----------- ] | Death-associated protein kinase 3(E.C.2.7.1.37); kinase fold, phosphothreonine, TRANSFERASE; HET: TPO; 3.1A {Homo sapiens} |
96 | 3QUP_A | 323 | 251 | 100.0 | 5.1E-35 | [------------ ] | Tyrosine-protein kinase receptor TYRO3 (E.C.2.7.10.1); protein kinase inhibitor, receptor tyrosine; HET: LUN; 1.9A {Mus musculus} |
97 | 5JFW_A | 308 | 251 | 100.0 | 8.9E-35 | [------------ ] | High affinity nerve growth factor; TrkA inhibitor complex, HYDROLASE-HYDROLASE INHIBITOR; HET: 6K2; 1.52A {Homo sapiens} |
98 | 1PHK_A | 298 | 243 | 100.0 | 1.4E-34 | [----------- ] | PHOSPHORYLASE KINASE, ADENOSINE-5'-TRIPHOSPHATE; GLYCOGEN METABOLISM, TRANSFERASE, SERINE/THREONINE-PROTEIN, KINASE; HET: ATP; 2.2A {Oryctolagus cuniculus} SCOP: d.144.1.7 |
99 | 5O2C_A | 380 | 255 | 100.0 | 2.2E-35 | [------------ ] | FAM83B; WNK3, Structural Genomics, Structural Genomics; HET: GOL; 2.4A {Homo sapiens} |
100 | 4XUF_B | 297 | 248 | 100.0 | 6.3E-35 | [------------ ] | FLT3 (E.C.2.7.10.1); FLT3, receptor tyrosine kinase, AC220; HET: P30; 3.2A {Homo sapiens} |
101 | 5EYK_B | 276 | 245 | 100.0 | 4.6E-35 | [------------ ] | Aurora kinase B-A (E.C.2.7.11.1), Inner; KINASE, Inhibitor, transferase; HET: TPO, 5U5; 1.93A {Xenopus laevis} |
102 | 3H10_A | 268 | 239 | 100.0 | 8.4E-35 | [----------- ] | Serine/threonine-protein kinase 6 (E.C.2.7.11.1); Protein:Inhibitor complex Aurora-A, Cell cycle; HET: 97B; 2.2A {Homo sapiens} |
103 | 4YJR_A | 281 | 250 | 100.0 | 6.6E-35 | [------------ ] | Tyrosine-protein kinase SYK (E.C.2.7.10.2); SYK, NON-RECEPTOR TYROSINE KINASE, SPLEEN; HET: PTR, 4DJ; 1.32A {Homo sapiens} |
104 | 2H34_B | 309 | 254 | 100.0 | 1.1E-34 | [------------ ] | Apoenzyme crystal structure of the; apoenzyme, serine/threonine protein kinase, TRANSFERASE; 2.8A {Mycobacterium tuberculosis} |
105 | 4RA5_A | 334 | 239 | 100.0 | 7E-35 | [----------- ] | HUMAN PROTEIN KINASE C THETA; PKC THETA KINASE, kinase domain; HET: 3L0; 2.61A {Homo sapiens} |
106 | 4OTD_A | 341 | 237 | 100.0 | 1.5E-34 | [----------- ] | Serine/threonine-protein kinase N1 (E.C.2.7.11.13); PRK1, PKN1, Protein kinase C; 2.0A {Homo sapiens} |
107 | 4AS0_A | 273 | 238 | 100.0 | 1.3E-35 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE PIM-1 (E.C.2.7.11.1); TRANSFERASE, PIM1, OCTASPORINE, RUTHENIUM, KINASE; HET: RPS; 2.3A {HOMO SAPIENS} |
108 | 5NKF_A | 306 | 252 | 100.0 | 1.1E-34 | [------------ ] | Ephrin type-A receptor 2 (E.C.2.7.10.1); Inhibitor, Complex, Protein Tyrosine Kinase; HET: 8ZN; 1.099A {Homo sapiens} |
109 | 4OW8_A | 283 | 243 | 100.0 | 8.4E-35 | [----------- ] | Transmembrane serine/threonine-protein kinase A PknA; PknA, kinase, drug target, Mtb; 2.03A {Mycobacterium tuberculosis} |
110 | 3QHR_A | 298 | 257 | 100.0 | 8.4E-35 | [------------ ] | Cell division protein kinase 2; kinase catalytic domain, protein kinase; HET: GOL, ADP; 2.17A {Homo sapiens} |
111 | 5LWM_A | 294 | 255 | 100.0 | 4E-35 | [------------ ] | Tyrosine-protein kinase JAK3 (E.C.2.7.10.2); Transferase, Kinase, JAK3, covalent inhibitor; HET: PHU, 79T, EDO; 1.55A {Homo sapiens} |
112 | 4Y73_C | 302 | 254 | 100.0 | 1.8E-34 | [------------ ] | INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4 (E.C.2.7.11.1); Kinase, Inhibitor; HET: XPY, TPO, SEP; 2.14A {Homo sapiens} |
113 | 3BU3_A | 306 | 250 | 100.0 | 1.3E-34 | [------------ ] | Insulin receptor precursor (EC 2.7.10.1); IRK, KRLB, IRS2, insulin receptor; 1.65A {Homo sapiens} SCOP: d.144.1.7 |
114 | 5LVO_A | 311 | 250 | 100.0 | 8.5E-35 | [------------ ] | 3-phosphoinositide-dependent protein kinase 1 (E.C.2.7.11.1); protein kinase, allosteric regulation, small; HET: DMS, ATP, 78W, SEP; 1.09A {Homo sapiens} |
115 | 5J87_B | 274 | 244 | 100.0 | 1E-34 | [------------ ] | Tyrosine-protein kinase BTK (E.C.2.7.10.2); BTK, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: N42; 1.59A {Homo sapiens} |
116 | 3F66_B | 298 | 253 | 100.0 | 1.4E-34 | [------------ ] | Hepatocyte growth factor receptor (E.C.2.7.10.1); c-Met, protein kinase, quinoxaline, Alternative; HET: GBL, IHX; 1.4A {Homo sapiens} |
117 | 3BHY_A | 283 | 247 | 100.0 | 5.7E-35 | [----------- ] | Death-associated protein kinase 3 (E.C.2.7.11.1); Death Associated Kinase, DAPK3, ZIP; HET: 7CP; 1.24A {Homo sapiens} |
118 | 4E1Z_A | 291 | 250 | 100.0 | 1.3E-34 | [------------ ] | Non-receptor tyrosine-protein kinase TYK2 (E.C.2.7.10.2); kinase catalytic domain, kinase, TRANSFERASE-TRANSFERASE; HET: 0MX; 2.5A {Mus musculus} |
119 | 5FXS_A | 308 | 255 | 100.0 | 8.2E-35 | [------------ ] | INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; TRANSFERASE; HET: ACT, OZN; 1.9A {HOMO SAPIENS} |
120 | 3EYH_A | 290 | 250 | 100.0 | 6E-35 | [------------ ] | Tyrosine-protein kinase (E.C.2.7.10.2); JAK kinase, ATP-binding, Kinase, Nucleotide-binding; HET: IZA; 2.0A {Homo sapiens} |
121 | 2VWI_D | 303 | 249 | 100.0 | 4.8E-35 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE OSR1 (E.C.2.7.11.1); KINASE, STE KINASE, HYPERTENSION, TRANSFERASE; HET: AU, ANP; 2.15A {HOMO SAPIENS} |
122 | 2WTK_B | 373 | 258 | 100.0 | 1.6E-34 | [------------ ] | CALCIUM-BINDING PROTEIN 39, STE20-RELATED KINASE; TRANSFERASE-METAL-BINDING PROTEIN COMPLEX, TRANSFERASE METAL-BINDING; HET: ANP; 2.65A {HOMO SAPIENS} |
123 | 3UC3_A | 361 | 239 | 100.0 | 1E-34 | [----------- ] | Serine/threonine-protein kinase SRK2I (E.C.2.7.11.1); SnRK2, kinase, ABA signaling, TRANSFERASE; 1.9A {Arabidopsis thaliana} |
124 | 3DLS_A | 335 | 245 | 100.0 | 2.2E-35 | [------------ ] | PAS domain-containing serine/threonine-protein kinase (E.C.2.7.11.1); PAS KINASE, PASK, PROTEIN KINASE; HET: ADP, MG; 2.3A {Homo sapiens} |
125 | 5DE2_A | 310 | 250 | 100.0 | 9.5E-35 | [------------ ] | Serine/threonine-protein kinase Nek7 (E.C.2.7.11.1), Serine/threonine-protein; Protein kinase, mitosis, protein-protein interaction; 2.78A {Homo sapiens} |
126 | 3AQV_A | 276 | 240 | 100.0 | 4.9E-35 | [----------- ] | 5'-AMP-activated protein kinase catalytic subunit; Structural Genomics, RIKEN Structural Genomics/Proteomics; HET: TAK; 2.08A {Homo sapiens} |
127 | 5J5T_A | 370 | 244 | 100.0 | 7E-35 | [----------- ] | Mitogen-activated protein kinase kinase kinase; Protein kinsae, Transferase-Transferase Inhibitor complex; HET: TPO, 6G2; 2.85A {Homo sapiens} |
128 | 3DLS_D | 335 | 235 | 100.0 | 2.6E-35 | [----------- ] | PAS domain-containing serine/threonine-protein kinase (E.C.2.7.11.1); PAS KINASE, PASK, PROTEIN KINASE; HET: MG, ADP; 2.3A {Homo sapiens} |
129 | 3KN5_B | 325 | 253 | 100.0 | 2E-34 | [------------ ] | Ribosomal protein S6 kinase alpha-5; KINASE, AMP-PNP, MSK1, MSK, ATP-BINDING; HET: ANP; 2.4A {Homo sapiens} |
130 | 3ZOS_B | 315 | 253 | 100.0 | 1.3E-34 | [------------ ] | EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1; TRANSFERASE, RTK, COLLAGEN, DISCOIDIN DOMAIN; HET: EDO, 0LI; 1.92A {HOMO SAPIENS} |
131 | 3KN6_B | 325 | 252 | 100.0 | 9.3E-35 | [------------ ] | Ribosomal protein S6 kinase alpha-5; KINASE, AMP-PNP, MSK1, MSK, ATP-BINDING; 2.0A {Homo sapiens} |
132 | 4LV8_A | 371 | 245 | 100.0 | 3.1E-35 | [----------- ] | Rhoptry protein 5 C, Interferon-inducible; immune related GTPase, guanine dissociation; HET: GDP, ADP, EDO; 1.72A {Toxoplasma gondii type I} |
133 | 2E9V_A | 268 | 244 | 100.0 | 1.8E-35 | [----------- ] | Serine/threonine-protein kinase Chk1 (E.C.2.7.11.1); Protein-inhibitor Complex, TRANSFERASE; HET: 85A; 2.0A {Homo sapiens} SCOP: d.144.1.7 |
134 | 4I5P_A | 308 | 263 | 100.0 | 3.1E-34 | [------------ ] | Serine/threonine-protein kinase PLK2 (E.C.2.7.11.21); Polo-like kinase-2 (Plk-2), Synuclein, Parkinson's; HET: 1D1; 1.738A {Homo sapiens} |
135 | 5UT3_A | 289 | 259 | 100.0 | 4.8E-35 | [------------ ] | Tyrosine-protein kinase JAK2 (E.C.2.7.10.2); Pseudokinase Domain, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: IK1, GOL; 1.501A {Homo sapiens} |
136 | 4EQM_B | 294 | 257 | 100.0 | 1.6E-34 | [------------ ] | Protein kinase; Kinase, serine/threonine protein kinase, TRANSFERASE; HET: ANP, BEN; 3.0A {Staphylococcus aureus subsp. aureus} |
137 | 4BKJ_A | 315 | 253 | 100.0 | 1.1E-34 | [------------ ] | EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1; TRANSFERASE, RECEPTOR, RTK, COLLAGEN, DISCOIDIN; HET: STI, EDO; 1.7A {HOMO SAPIENS} |
138 | 4YZN_A | 287 | 250 | 100.0 | 5.9E-35 | [------------ ] | Humanized Roco4 Kinase Domain; Roco-Protein, Kinase, LRRK2, Inhibitor, Roco4; HET: 4K5; 1.55A {Dictyostelium discoideum} |
139 | 2YEX_A | 276 | 242 | 100.0 | 4.4E-35 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE CHK1 (E.C.2.7.11.1); TRANSFERASE, CELL CYCLE, CHK; HET: GOL, YEX; 1.3A {HOMO SAPIENS} |
140 | 5T18_A | 267 | 244 | 100.0 | 1.2E-34 | [------------ ] | Tyrosine-protein kinase BTK (E.C.2.7.10.2); KINASE, BTK, ATK, XLA, PSCTK1; HET: 73T; 1.5A {Homo sapiens} |
141 | 2C47_D | 313 | 281 | 100.0 | 9.2E-35 | [------------- ] | CASEIN KINASE 1 GAMMA 2; SERINE/THREONINE KINASE, ACTIN CYTOSKELETON ORGANISATION; HET: 5ID; 2.4A {HOMO SAPIENS} |
142 | 4GT4_A | 308 | 249 | 100.0 | 2.6E-34 | [------------ ] | Tyrosine-protein kinase transmembrane receptor ROR2; ATP binding, phosphorylation, membrane, TRANSFERASE; HET: NO3; 2.406A {Homo sapiens} |
143 | 2VZ6_B | 313 | 258 | 100.0 | 1.9E-34 | [------------ ] | CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, CELL; HET: FEF, PGO; 2.3A {HOMO SAPIENS} |
144 | 5EH0_A | 258 | 229 | 100.0 | 2.7E-34 | [----------- ] | Monopolar Spindle kinase 1 (MPS1); Spindle Assembly Checkpoint (SAC), Oncology; HET: 5NW; 2.18A {N/A} |
145 | 5CI6_B | 370 | 252 | 100.0 | 4.7E-34 | [------------ ] | Mitogen-activated protein kinase 6 (E.C.2.7.11.24); Kinase, apoenzyme, TRANSFERASE; 3.0A {Arabidopsis thaliana} |
146 | 5KKR_B | 319 | 255 | 100.0 | 7.1E-34 | [------------ ] | Kinase suppressor of Ras 2; Kinase Suppressor of Ras Small; HET: 6U7; 3.509A {Homo sapiens} |
147 | 3COK_B | 278 | 242 | 100.0 | 4.5E-35 | [----------- ] | Serine/threonine-protein kinase PLK4 (E.C.2.7.11.21); PLK4, Polo-like kinase 4, SAK; HET: SO4, ANP; 2.25A {Homo sapiens} |
148 | 5U6B_B | 307 | 253 | 100.0 | 1.7E-34 | [------------ ] | Tyrosine-protein kinase receptor UFO (E.C.2.7.10.1); Kinase Inhibitor Complex, Transferase-Transferase Inhibitor; HET: 7YS; 2.84A {Homo sapiens} |
149 | 4ITJ_A | 294 | 259 | 100.0 | 2.3E-34 | [------------ ] | Receptor-interacting serine/threonine-protein kinase 1 (E.C.2.7.11.1); alpha/beta, RIP1 kinase, necroptosis, necrostatins; HET: 1HX; 1.8A {Homo sapiens} |
150 | 4EUU_A | 319 | 258 | 100.0 | 7.3E-35 | [------------ ] | Serine/threonine-protein kinase TBK1 (E.C.2.7.11.1); Kinase, ATP Binding, Phosphorylation, TRANSFERASE-TRANSFERASE; HET: GOL, BX7, SO4; 1.8A {Homo sapiens} |
151 | 4GV1_A | 340 | 252 | 100.0 | 2.1E-34 | [------------ ] | RAC-alpha serine/threonine-protein kinase (E.C.2.7.11.1); protein kinase, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: 0XZ, GOL; 1.49A {Homo sapiens} |
152 | 2Z2W_A | 285 | 243 | 100.0 | 3.3E-34 | [----------- ] | Wee1-like protein kinase (E.C.2.7.10.2); wee1 kinase, inhibitor complex, TRANSFERASE; HET: 770; 2.22A {Homo sapiens} |
153 | 4M68_A | 283 | 253 | 100.0 | 4.6E-35 | [------------ ] | Mixed lineage kinase domain-like protein; Kinase-like, substrate of RIP3, RIP3; 1.696A {Mus musculus} |
154 | 4ITJ_B | 294 | 259 | 100.0 | 2.4E-34 | [------------ ] | Receptor-interacting serine/threonine-protein kinase 1 (E.C.2.7.11.1); alpha/beta, RIP1 kinase, necroptosis, necrostatins; HET: 1HX; 1.8A {Homo sapiens} |
155 | 5JZN_A | 280 | 243 | 100.0 | 4E-35 | [----------- ] | Serine/threonine-protein kinase DCLK1 (E.C.2.7.11.1); kinase, doublecortin, TRANSFERASE; HET: GUI; 2.85A {Homo sapiens} |
156 | 3PLS_A | 298 | 253 | 100.0 | 1.6E-34 | [------------ ] | Macrophage-stimulating protein receptor (E.C.2.7.10.1); PROTEIN KINASE, cis autophosphorylation conformation; HET: ANP; 2.24A {Homo sapiens} |
157 | 1UNL_A | 292 | 247 | 100.0 | 3E-34 | [----------- ] | CYCLIN-DEPENDENT KINASE 5 (E.C.2.7.1.-), CYCLIN-DEPENDENT; CYCLIN DEPENDENT KINASE, INHIBITOR, ATP-ANALOGUE; HET: RRC; 2.2A {HOMO SAPIENS} SCOP: d.144.1.7 |
158 | 1CSN_A | 298 | 261 | 100.0 | 7.7E-35 | [------------ ] | CASEIN KINASE-1, ADENOSINE-5'-TRIPHOSPHATE; PHOSPHOTRANSFERASE; HET: SO4, ATP; 2.0A {Schizosaccharomyces pombe} SCOP: d.144.1.7 |
159 | 5L8L_A | 285 | 258 | 100.0 | 1.7E-34 | [------------ ] | Aurora kinase A (E.C.2.7.11.1), New; kinase, vNAR, inhibitor, transferase; HET: ADP, TPO, EDO, SO4; 1.67A {Homo sapiens} |
160 | 4FVQ_A | 289 | 259 | 100.0 | 7.7E-35 | [------------ ] | Tyrosine-protein kinase JAK2 (E.C.2.7.10.2); JANUS PROTEIN KINASE, PSEUDOKINASE, ATP; HET: ATP; 1.75A {Homo sapiens} |
161 | 4LV5_A | 371 | 244 | 100.0 | 6.7E-36 | [----------- ] | Rhoptry protein 5B, Interferon-inducible GTPase; immune related GTPase, guanine dissociation; HET: GDP, ADP, EDO; 1.7A {Toxoplasma gondii} |
162 | 4KNB_D | 287 | 250 | 100.0 | 1.9E-34 | [------------ ] | Hepatocyte growth factor receptor (E.C.2.7.10.1); protein kinase, TRANSFERASE; HET: 1RU, GBL; 2.4A {Homo sapiens} |
163 | 3BYV_A | 377 | 245 | 100.0 | 1.1E-35 | [------------ ] | Rhoptry kinase; toxoplasma, 33.m00005, rhoptry, malaria, kinase; HET: EDO; 1.8A {Toxoplasma gondii} |
164 | 2IZR_A | 330 | 261 | 100.0 | 7.5E-35 | [------------ ] | CASEIN KINASE I ISOFORM GAMMA-3; SERINE/THREONINE-PROTEIN KINASE, KINASE, TRANSFERASE, ATP-BINDING; HET: BRK; 1.3A {HOMO SAPIENS} |
165 | 4NT4_A | 312 | 266 | 100.0 | 5.8E-35 | [------------ ] | Gilgamesh, isoform I (E.C.2.7.11.-); Serine/threonine protein kinase, Wnt signaling; HET: SO4; 2.86A {Drosophila melanogaster} |
166 | 5DA3_A | 265 | 245 | 100.0 | 1.2E-34 | [------------ ] | Protein-tyrosine kinase 6 (E.C.2.7.10.2); PTK6, BRK, Complex, Inhibitor, Kinase; HET: GOL, 58V, CXM; 1.7A {Homo sapiens} |
167 | 1QPC_A | 279 | 247 | 100.0 | 2E-34 | [------------ ] | LCK KINASE; ALPHA BETA FOLD, TRANSFERASE; HET: ANP, PTR, SO4; 1.6A {Homo sapiens} SCOP: d.144.1.7 |
168 | 3WF7_A | 329 | 238 | 100.0 | 2.5E-34 | [----------- ] | Ribosomal protein S6 kinase beta-1; SERINE/THREONINE PROTEIN KINASE DOMAIN, TRANSFERASE; HET: FS9; 1.85A {Homo sapiens} |
169 | 3BZ3_A | 276 | 247 | 100.0 | 5.5E-34 | [------------ ] | Focal adhesion kinase 1 (E.C.2.7.10.2); kinase, DFG-helix, ATP-binding, Cell junction; HET: YAM; 2.2A {Homo sapiens} SCOP: d.144.1.7 |
170 | 4QQT_A | 323 | 250 | 100.0 | 1.1E-33 | [------------ ] | Fibroblast growth factor receptor 4; Kinase Domain Fold, Cell Signaling; HET: SO4; 1.501A {Homo sapiens} |
171 | 4E5W_B | 302 | 250 | 100.0 | 1.1E-34 | [------------ ] | Tyrosine-protein kinase JAK1 (E.C.2.7.10.2); JAK1, kinase domain, kinase, TRANSFERASE-TRANSFERASE; HET: 0NT; 1.86A {Homo sapiens} |
172 | 3S95_A | 310 | 260 | 100.0 | 6E-35 | [------------ ] | LIM domain kinase 1 (E.C.2.7.11.1); Structural Genomics, Structural Genomics Consortium; HET: GOL, TRS, STU; 1.65A {Homo sapiens} |
173 | 5CI6_A | 370 | 252 | 100.0 | 5.1E-34 | [------------ ] | Mitogen-activated protein kinase 6 (E.C.2.7.11.24); Kinase, apoenzyme, TRANSFERASE; 3.0A {Arabidopsis thaliana} |
174 | 4AU8_B | 296 | 247 | 100.0 | 2.7E-34 | [----------- ] | CYCLIN-DEPENDENT KINASE 5 (E.C.2.7.11.22); TRANSFERASE, CDK2, ALZHEIMER DISEASE; HET: Z3R, SO4; 1.9A {HOMO SAPIENS} |
175 | 3DXN_A | 287 | 246 | 100.0 | 3.6E-34 | [----------- ] | Calmodulin-like domain protein kinase isoform; cdpk, calcium dependent kinase, calmodulin; 2.17A {Toxoplasma gondii} |
176 | 4OTH_A | 341 | 237 | 100.0 | 1.5E-34 | [----------- ] | Serine/threonine-protein kinase N1 (E.C.2.7.11.13); PRK1, PKN1, Protein kinase C; HET: DRN; 1.8A {Homo sapiens} |
177 | 4R1V_A | 291 | 251 | 100.0 | 2.3E-34 | [------------ ] | Hepatocyte growth factor receptor (E.C.2.7.10.1); PROTEIN KINASE, Transferase, TRANSFERASE-TRANSFERASE INHIBITOR; HET: 3E8, GBL; 1.2A {Homo sapiens} |
178 | 4UY9_B | 323 | 250 | 100.0 | 3.5E-34 | [------------ ] | MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE; MLK FAMILY, MLK1 AND MLK3; 2.81A {HOMO SAPIENS} |
179 | 2OGV_A | 317 | 249 | 100.0 | 1.7E-34 | [------------ ] | Macrophage colony-stimulating factor 1 receptor; RECEPTOR TYROSINE KINASE, MACROPHAGE COLONY; 2.7A {Homo sapiens} |
180 | 3I6U_A | 419 | 253 | 100.0 | 6.7E-35 | [------------ ] | Serine/threonine-protein kinase Chk2 (E.C.2.7.11.1); Ser/Thr protein kinase, FHA domain; 3.0A {Homo sapiens} |
181 | 2AC3_A | 316 | 252 | 100.0 | 2.7E-34 | [----------- ] | MAP kinase-interacting serine/threonine kinase 2; DFD motif, TRANSFERASE; 2.1A {Homo sapiens} |
182 | 2OF2_A | 271 | 245 | 100.0 | 1.9E-34 | [------------ ] | Proto-oncogene tyrosine-protein kinase LCK (E.C.2.7.10.2); lck, kinase domain, TRANSFERASE; HET: 547; 2.0A {Homo sapiens} SCOP: d.144.1.7 |
183 | 4USF_A | 304 | 240 | 100.0 | 4.4E-34 | [----------- ] | STE20-LIKE SERINE/THREONINE-PROTEIN KINASE (E.C.2.7.11.1); TRANSFERASE; HET: 6UI; 1.75A {HOMO SAPIENS} |
184 | 1FOT_A | 318 | 235 | 100.0 | 3.8E-34 | [----------- ] | AMP-DEPENDENT PROTEIN KINASE TYPE 1; cAMP-dependent Protein Kinase, open conformation; 2.8A {Saccharomyces cerevisiae} SCOP: d.144.1.7 |
185 | 4MWI_A | 294 | 253 | 100.0 | 8.6E-34 | [------------ ] | Mixed lineage kinase domain-like protein; Pseudokinase, necroptosis, transferase; HET: PXN; 1.7A {Homo sapiens} |
186 | 4Z55_A | 339 | 255 | 100.0 | 4E-34 | [------------ ] | ALK tyrosine kinase receptor (E.C.2.7.10.1); catalytic domain, transferase, inhibitor, Transferase-Transferase; HET: GOL, 4LO; 1.55A {Homo sapiens} |
187 | 2F57_B | 317 | 241 | 100.0 | 7.1E-34 | [----------- ] | Serine/threonine-protein kinase PAK 7 (E.C.2.7.1.37); Pak5, Kinase domains, GroupII PAKs; HET: TRS, 23D; 1.8A {Homo sapiens} |
188 | 4BTK_A | 337 | 255 | 100.0 | 2.2E-34 | [------------ ] | TAU-TUBULIN KINASE 1 (E.C.2.7.11.1, 2.7.11.26); TRANSFERASE, STRUCTURE-KINETICS RELATIONSHIP; HET: DTQ; 2.0A {HOMO SAPIENS} |
189 | 5KO1_A | 283 | 252 | 100.0 | 8.3E-34 | [------------ ] | Mixed lineage kinase domain-like protein; Pseudokinase domain MLKL Type1 inhibitor; HET: 6UY; 2.16A {Homo sapiens} |
190 | 4E6Q_B | 298 | 251 | 100.0 | 1.8E-34 | [------------ ] | Tyrosine-protein kinase JAK2 (E.C.2.7.10.2); JAK2, kinase domain, TRANSFERASE-TRANSFERASE INHIBITOR; HET: 0NV; 1.948A {Homo sapiens} |
191 | 1T46_A | 313 | 247 | 100.0 | 4.2E-34 | [------------ ] | Homo sapiens v-kit Hardy-Zuckerman 4; KINASE, INHIBITOR, STI-571, Gleevec, TRANSFERASE; HET: STI, PO4; 1.6A {Homo sapiens} SCOP: d.144.1.7 |
192 | 3T9T_A | 267 | 246 | 100.0 | 4.8E-34 | [------------ ] | Tyrosine-protein kinase ITK/TSK (E.C.2.7.10.2); kinase domain, alpha/beta, ATP binding; HET: GOL, IAQ; 1.65A {Homo sapiens} |
193 | 5L2Q_A | 320 | 253 | 100.0 | 1.2E-33 | [------------ ] | Serine/threonine-protein kinase 40 (E.C.2.7.11.1); pseudokinase SINK-homologous serine/threonine-protein kinase Sugen; 2.53A {Homo sapiens} |
194 | 2WEI_A | 287 | 245 | 100.0 | 4.3E-34 | [----------- ] | CALMODULIN-DOMAIN PROTEIN KINASE 1, PUTATIVE; NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, KINASE, TRANSFERASE; HET: VGG; 1.65A {CRYPTOSPORIDIUM PARVUM IOWA II} |
195 | 4YFF_A | 311 | 251 | 100.0 | 3.8E-34 | [------------ ] | TNNI3K (E.C.2.7.11.1); kinase, Transferase-Transferase Inhibitor complex; HET: 4CV; 3.07A {Homo sapiens} |
196 | 4W9W_A | 306 | 264 | 100.0 | 2.9E-34 | [------------ ] | BMP-2-inducible kinase (E.C.2.7.11.1); kinase, small-molecule, catalytic domain, protein; HET: YDJ, EDO; 1.72A {Homo sapiens} |
197 | 3FAM_B | 275 | 239 | 100.0 | 2.3E-34 | [----------- ] | Carbon catabolite derepressing protein kinase; Kinase domain, TRANSFERASE, ATP-binding, Carbohydrate; 2.2A {Saccharomyces cerevisiae} |
198 | 4FKL_A | 299 | 255 | 100.0 | 2.6E-34 | [------------ ] | Cyclin-dependent kinase 2 (E.C.2.7.11.22); ALPHA AND BETA PROTEIN (A+B); HET: CK2; 1.26A {Homo sapiens} |
199 | 4MVF_A | 506 | 244 | 100.0 | 1E-34 | [----------- ] | Calcium-dependent protein kinase 2 (E.C.2.7.11.1); EF-HANDS, PROTEIN S/T KINASE, TRANSFERASE-TRANSFERASE; HET: STU; 2.0A {Plasmodium falciparum K1} |
200 | 5HVK_A | 315 | 259 | 100.0 | 1.2E-34 | [------------ ] | LIM domain kinase 1 (E.C.2.7.11.1); kinase substrate actin-remodeling, TRANSFERASE; HET: TPO, ANP, SEP; 3.5A {Homo sapiens} |
201 | 3GNI_B | 389 | 260 | 100.0 | 5.4E-34 | [------------ ] | Calcium-binding protein 39, STE20-related kinase; kinase fold, pseudokinase, alpha helical; HET: CIT, ATP; 2.35A {Homo sapiens} |
202 | 1XJD_A | 345 | 239 | 100.0 | 4.7E-34 | [----------- ] | Crystal Structure of PKC-theta complexed; KINASE, PKC-theta, AMP,, TRANSFERASE; HET: STU; 2.0A {Homo sapiens} SCOP: d.144.1.7 |
203 | 4BTJ_B | 337 | 255 | 100.0 | 2.7E-34 | [------------ ] | TAU-TUBULIN KINASE 1 (E.C.2.7.11.1, 2.7.11.26); TRANSFERASE, LIGAND COMPLEX, STRUCTURE-KINETICS RELATIONSHIP; HET: ATP, ADP, PO4; 2.16A {HOMO SAPIENS} |
204 | 5CZO_B | 395 | 257 | 100.0 | 4.3E-34 | [------------ ] | Casein kinase I homolog HRR25; casein kinase, monopolin, TRANSFERASE; HET: MLY; 2.894A {Saccharomyces cerevisiae (strain ATCC 204508 / S288c)} |
205 | 4OTW_A | 326 | 248 | 100.0 | 1.5E-34 | [------------ ] | Receptor tyrosine-protein kinase erbB-3 (E.C.2.7.10.1); RECEPTOR TYROSINE KINASE, PSEUDOKINASE, BOSUTINIB; HET: DB8; 2.506A {Homo sapiens} |
206 | 4AAA_A | 331 | 247 | 100.0 | 6.6E-34 | [----------- ] | CYCLIN-DEPENDENT KINASE-LIKE 2 (E.C.2.7.11.22); TRANSFERASE, PHOSPHO-MIMETIC; HET: DKI, EDO; 1.53A {HOMO SAPIENS} |
207 | 5VND_A | 309 | 251 | 100.0 | 1.2E-33 | [------------ ] | Fibroblast growth factor receptor 1; FGFR4, H3B-56527, Covalent compound, transferase-transferase; HET: 9ES, SO4, EDO; 2.2A {Homo sapiens} |
208 | 4D4R_B | 276 | 249 | 100.0 | 3.3E-34 | [------------ ] | FOCAL ADHESION KINASE 1 (E.C.2.7.10.2); TRANSFERASE, KINASE INHIBITOR, ATP-BINDING, INTEGRIN; HET: SO4; 1.55A {GALLUS GALLUS} |
209 | 2FH9_A | 274 | 239 | 100.0 | 1E-34 | [----------- ] | Snf1 kinase (E.C.2.7.1.-); kinase domain dimer, SIGNALING; 2.8A {Saccharomyces cerevisiae} |
210 | 1P4O_B | 322 | 256 | 100.0 | 4.5E-34 | [------------ ] | Insulin-like growth factor I receptor; IGF-1R, Kinase domain, HORMONE-GROWTH FACTOR; 1.5A {Homo sapiens} SCOP: d.144.1.7 |
211 | 4C2V_A | 285 | 238 | 100.0 | 5.8E-34 | [----------- ] | AURORA KINASE B-A (E.C.2.7.11.1), INNER; TRANSFERASE-CELL CYCLE COMPLEX, AZD1152; HET: YJA; 1.49A {XENOPUS LAEVIS} |
212 | 2I0E_B | 353 | 239 | 100.0 | 4.2E-34 | [----------- ] | Protein Kinase C-beta II (E.C.2.7.11.13); Protein Kinase C Beta II; HET: PDS; 2.6A {Homo sapiens} |
213 | 4FG7_A | 293 | 244 | 100.0 | 5.3E-34 | [----------- ] | Calcium/calmodulin-dependent protein kinase type 1; CaMK, calmodulin, autoinhibition, regulation mechanism; HET: ATP; 2.7A {Homo sapiens} |
214 | 4WSQ_A | 317 | 262 | 100.0 | 4.4E-34 | [------------ ] | Adaptor protein 2 associated protein; kinase, small-molecule, catalytic domain, protein; HET: KSA; 1.95A {Homo sapiens} |
215 | 3FE3_B | 328 | 238 | 100.0 | 6.2E-34 | [----------- ] | MAP/microtubule affinity-regulating kinase 3 (E.C.2.7.11.1); SERINE/THREONINE PROTEIN KINASE MARK; 1.9A {Homo sapiens} |
216 | 3U6J_A | 314 | 249 | 100.0 | 9.4E-34 | [------------ ] | Vascular endothelial growth factor receptor; KDR, Flk-1, angiogenesis, phosphotransferase, cancer; HET: 03X; 2.15A {Homo sapiens} |
217 | 3ZDU_A | 325 | 244 | 100.0 | 2.8E-34 | [----------- ] | CYCLIN-DEPENDENT KINASE-LIKE 3 (E.C.2.7.11.22); TRANSFERASE, PHOSPHO-MIMETIC; HET: 38R; 2.2A {HOMO SAPIENS} |
218 | 1LUF_A | 343 | 252 | 100.0 | 4.8E-34 | [------------ ] | Muscle-specific Tyrosine Kinase receptor musk; phosphorylation, signal transduction, mass spectrometry; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 |
219 | 4LQS_A | 508 | 258 | 100.0 | 1.4E-34 | [------------ ] | Serine/threonine-protein kinase CBK1 (E.C.2.7.11.1), CBK1; Kinase, TRANSFERASE-TRANSFERASE activator complex; HET: ANP; 3.3A {Saccharomyces cerevisiae} |
220 | 2RIO_A | 434 | 250 | 100.0 | 3.4E-34 | [----------- ] | Serine/threonine-protein kinase/endoribonuclease IRE1; Protein-nucleotide complex, ATP-binding, Endoplasmic reticulum; HET: ADP; 2.4A {Saccharomyces cerevisiae} |
221 | 4BBM_A | 331 | 247 | 100.0 | 4.1E-34 | [----------- ] | CYCLIN-DEPENDENT KINASE-LIKE 2 (E.C.2.7.11.22); TRANSFERASE, PHOSPHO-MIMETIC; HET: TC0, EDO; 2.0A {HOMO SAPIENS} |
222 | 2QNJ_B | 328 | 239 | 100.0 | 8.6E-34 | [----------- ] | MAP/microtubule affinity-regulating kinase 3 (E.C.2.7.11.1); serine/threonine protein kinase, ubiquitin-associated domain; 2.7A {Homo sapiens} |
223 | 5DRB_A | 291 | 243 | 100.0 | 4.7E-34 | [----------- ] | Serine/threonine-protein kinase WNK1 (E.C.2.7.11.1); kinase, inhibitor, complex, TRANSFERASE-TRANSFERASE INHIBITOR; HET: 5FJ; 1.65A {Rattus norvegicus} |
224 | 1UA2_B | 346 | 255 | 100.0 | 8.1E-34 | [------------ ] | Cell division protein kinase 7; CELL CYCLE PHOSPHORYLATION ; HET: ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 |
225 | 4BC6_A | 293 | 241 | 100.0 | 5.6E-34 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE 10 (E.C.2.7.11.1); TRANSFERASE; HET: XZN; 2.2A {HOMO SAPIENS} |
226 | 3ORK_A | 311 | 259 | 100.0 | 1.5E-34 | [------------ ] | Serine/threonine protein kinase; Structural Genomics, TB Structural Genomics; HET: AGS; 1.6A {Mycobacterium tuberculosis} |
227 | 5L2Q_B | 320 | 252 | 100.0 | 1.2E-33 | [------------ ] | Serine/threonine-protein kinase 40 (E.C.2.7.11.1); pseudokinase SINK-homologous serine/threonine-protein kinase Sugen; 2.53A {Homo sapiens} |
228 | 5GRN_A | 356 | 250 | 100.0 | 7.7E-34 | [------------ ] | Platelet-derived growth factor receptor alpha,Platelet-derived; PDGFRA, WQ-C-159, inhibitor, TRANSFERASE-TRANSFERASE INHIBITOR; HET: 748; 1.77A {Homo sapiens} |
229 | 4X7K_A | 317 | 259 | 100.0 | 2E-34 | [------------ ] | EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA; CATALYTIC DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR, COMPLEX; HET: 3Z3, TLA; 1.8A {Homo sapiens} |
230 | 2I0E_A | 353 | 239 | 100.0 | 4.2E-34 | [----------- ] | Protein Kinase C-beta II (E.C.2.7.11.13); Protein Kinase C Beta II; HET: PDS; 2.6A {Homo sapiens} |
231 | 1ZXE_C | 303 | 257 | 100.0 | 3E-34 | [------------ ] | GCN2 protein kinase domain with; Translation regulator, Protein kinase, Signal; HET: GOL; 2.6A {Saccharomyces cerevisiae} |
232 | 4AGU_C | 311 | 247 | 100.0 | 1.1E-33 | [----------- ] | CYCLIN-DEPENDENT KINASE-LIKE 1; TRANSFERASE, PHOSPHO-MIMETIC, KINASE; HET: D15; 2.4A {HOMO SAPIENS} |
233 | 1VZO_A | 355 | 254 | 100.0 | 3E-35 | [------------ ] | RIBOSOMAL PROTEIN S6 KINASE ALPHA; PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION, SERINE/THREONINE; 1.8A {HOMO SAPIENS} SCOP: d.144.1.7 |
234 | 5D7V_A | 269 | 246 | 100.0 | 6E-34 | [------------ ] | Protein-tyrosine kinase 6 (E.C.2.7.10.2); TRANSFERASE, KINASE, BRK, APO; HET: CXM, GOL, PO4; 2.33A {Homo sapiens} |
235 | 3A8X_A | 345 | 239 | 100.0 | 2.1E-33 | [----------- ] | Protein kinase C iota type; Protein kinase C iota, TRANSFERASE; HET: SO4; 2.0A {Homo sapiens} |
236 | 5P9J_A | 279 | 243 | 100.0 | 9.4E-34 | [------------ ] | Tyrosine-protein kinase BTK (E.C.2.7.10.2); kinase, kinase-ligand complex, TRANSFERASE; HET: 8E8; 1.08A {Homo sapiens} |
237 | 5O1V_A | 285 | 246 | 100.0 | 7.8E-34 | [------------ ] | FAM83B; WNK3, Structural Genomics, Structural Genomics; HET: EDO, SEP; 1.723A {Homo sapiens} |
238 | 4KS7_A | 292 | 259 | 100.0 | 1.1E-33 | [------------ ] | Serine/threonine-protein kinase PAK 6 (E.C.2.7.11.1); Protein kinase, Phosphotransfer, Phosphorylation, TRANSFERASE-TRANSFERASE; HET: X4Z; 1.4A {Homo sapiens} |
239 | 1AD5_A | 438 | 236 | 100.0 | 1E-33 | [------------ ] | HAEMATOPOETIC CELL KINASE HCK, PHOSPHOAMINOPHOSPHONIC; TYROSINE-PROTEIN KINASE, TRANSFERASE, SIGNAL TRANSDUCTION; HET: ANP; 2.6A {Homo sapiens} SCOP: d.93.1.1, d.144.1.7, b.34.2.1 |
240 | 5UOR_B | 270 | 241 | 100.0 | 3.6E-34 | [----------- ] | Mitogen-activated protein kinase kinase kinase; TRANSFERASE, METAL-BINDING, APOPTOSIS, TRANSFERASE-TRANSFERASE INHIBITOR; HET: 8GV, SO4; 2.75A {Homo sapiens} |
241 | 5K5X_A | 356 | 249 | 100.0 | 7.7E-34 | [------------ ] | Platelet-derived growth factor receptor alpha; tyrosine kinase, autoinhibition, TRANSFERASE; HET: SO4; 2.168A {Homo sapiens} |
242 | 5M06_B | 276 | 234 | 100.0 | 7E-34 | [------------ ] | Serine/threonine-protein kinase PknI (E.C.2.7.11.1); Tuberculosis, kinase, signalling, signaling protein; HET: ADP; 2.0A {Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)} |
243 | 5CYZ_A | 395 | 258 | 100.0 | 1.9E-34 | [------------ ] | Casein kinase I homolog HRR25; casein kinase, monopolin, TRANSFERASE; HET: MLY; 1.841A {Saccharomyces cerevisiae (strain ATCC 204508 / S288c)} |
244 | 4OR5_F | 326 | 259 | 100.0 | 6.5E-34 | [------------ ] | Cyclin-dependent kinase 9 (E.C.2.7.11.22, 2.7.11.23); Cdk9, Tat, AFF4, Zinc Finger; HET: SO4, YT3; 2.9A {Homo sapiens} |
245 | 2XIR_A | 316 | 250 | 100.0 | 9.2E-34 | [------------ ] | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR; ANGIOGENESIS, NUCLEOTIDE-BINDING, INHIBITOR, PHOSPHORYLATION, RECEPTOR; HET: 00J; 1.5A {N/A} |
246 | 3ZZ2_A | 293 | 241 | 100.0 | 8.5E-34 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE 10 (E.C.2.7.11.1); TRANSFERASE; HET: D88; 2.2A {HOMO SAPIENS} |
247 | 5UG9_A | 329 | 251 | 100.0 | 5.6E-34 | [------------ ] | Epidermal growth factor receptor (E.C.2.7.10.1); Kinase, covalent inhibitor, lung cancer; HET: 8AM, SO4, GOL; 1.33A {Homo sapiens} |
248 | 5LQF_D | 302 | 246 | 100.0 | 8.6E-34 | [----------- ] | Cyclin-dependent kinase 1 (E.C.2.7.11.22,2.7.11.23), G2/mitotic-specific; CDK1 CYCLIN B CKS2 CELL; HET: 4SP; 2.06A {Homo sapiens} |
249 | 3KEX_A | 325 | 250 | 100.0 | 2E-34 | [------------ ] | Receptor tyrosine-protein kinase erbB-3 (E.C.2.7.10.1); kinase domain, inactive kinase, HER3; HET: ANP; 2.797A {Homo sapiens} |
250 | 3FME_A | 290 | 240 | 100.0 | 1.1E-33 | [----------- ] | Dual specificity mitogen-activated protein kinase; kinase, active mutant, structural genomics; HET: STU; 2.26A {Homo sapiens} |
251 | 1X8B_A | 289 | 243 | 100.0 | 1.2E-33 | [----------- ] | Wee1-like protein kinase (E.C.2.7.1.112); kinase, cell cycle, wee1, TRANSFERASE; HET: 824; 1.81A {Homo sapiens} |
252 | 4WNO_A | 287 | 252 | 100.0 | 3.7E-33 | [------------ ] | ULK1; kinase, autophagy, inhibitor, TRANSFERASE-TRANSFERASE Inhibitor; HET: TPO, 3RF; 1.56A {Homo sapiens} |
253 | 1QCF_A | 454 | 246 | 100.0 | 9E-34 | [------------ ] | CRYSTAL STRUCTURE OF HCK IN; TYROSINE KINASE-INHIBITOR COMPLEX, DOWN-REGULATED KINASE; HET: PP1; 2.0A {Homo sapiens} SCOP: d.144.1.7, b.34.2.1, d.93.1.1 |
254 | 4IWD_A | 306 | 252 | 100.0 | 6.5E-34 | [------------ ] | Hepatocyte growth factor receptor (E.C.2.7.10.1); Protein kinase, tyrosine kinase, TRANSFERASE-TRANSFERASE; HET: 1JC; 1.99A {Homo sapiens} |
255 | 5DBX_A | 328 | 256 | 100.0 | 5.8E-34 | [------------ ] | STE20/SPS1-related proline-alanine-rich protein kinase (E.C.2.7.11.1); Kinase, TRANSFERASE; HET: CAS, ANP; 2.5A {Mus musculus} |
256 | 4UAK_A | 419 | 247 | 100.0 | 4.1E-34 | [----------- ] | MRCK beta (E.C.2.7.11.1); myotonic dystrophy kinase-related CDC42-binding kinase; HET: ADP; 1.73A {Homo sapiens} |
257 | 3BRB_B | 313 | 250 | 100.0 | 1.2E-33 | [------------ ] | Proto-oncogene tyrosine-protein kinase MER (E.C.2.7.10.1); ATP-BINDING, DISEASE MUTATION, GLYCOPROTEIN, KINASE; HET: ADP; 1.9A {Homo sapiens} |
258 | 3Q5I_A | 504 | 244 | 100.0 | 9.5E-34 | [----------- ] | Protein kinase; CDPK, plasmodium, malaria, calcium dependent; HET: ANP; 2.1A {Plasmodium berghei} |
259 | 2I6L_A | 320 | 260 | 100.0 | 2.3E-33 | [------------ ] | Mitogen-activated protein kinase 6 (E.C.2.7.11.24); MAPK6, ERK3, mitogen activated protein; 2.25A {Homo sapiens} |
260 | 3L8P_A | 317 | 248 | 100.0 | 1.1E-33 | [------------ ] | Angiopoietin-1 receptor (E.C.2.7.10.1); receptor tyrosine kinase, cytoplasmic kinase; HET: 0CE; 2.4A {Homo sapiens} |
261 | 3CC6_A | 281 | 250 | 100.0 | 1.7E-33 | [------------ ] | Protein tyrosine kinase 2 beta; FOCAL ADHESION KINASE, Structural Genomics; 1.6A {Homo sapiens} |
262 | 4L3J_A | 304 | 252 | 100.0 | 2.2E-33 | [------------ ] | RPS6KB1 protein; Protein kinase, TRANSFERASE; HET: 5FI; 2.1A {Homo sapiens} |
263 | 5CI7_A | 287 | 252 | 100.0 | 3.7E-33 | [------------ ] | Serine/threonine-protein kinase ULK1 (E.C.2.7.11.1); inhibitor, kinase, autophagy, TRANSFERASE-TRANSFERASE Inhibitor; HET: GOL, TPO, 51W; 1.74A {Homo sapiens} |
264 | 4UYA_A | 340 | 253 | 100.0 | 3.7E-34 | [------------ ] | MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE; MIXED-LINEAGE KINASE, ATP-BINDING, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN; HET: AGS; 2.8A {HOMO SAPIENS} |
265 | 3TXO_A | 353 | 250 | 100.0 | 1.8E-33 | [------------ ] | Protein kinase C eta type; kinase, phosphotransferase, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: 07U; 2.05A {Homo sapiens} |
266 | 2GCD_B | 309 | 238 | 100.0 | 1.7E-33 | [----------- ] | Serine/threonine-protein kinase TAO2 (E.C.2.7.1.37); TAO2, MAP3K, inhibitor, staurosporine, TRANSFERASE; HET: STU; 2.55A {Rattus norvegicus} SCOP: d.144.1.7 |
267 | 2QKW_B | 321 | 257 | 100.0 | 2.2E-34 | [------------ ] | Avirulence protein, Protein kinase (E.C.2.7.11.1); three-helix bundle motif, Avrpto-pto duplex; 3.2A {Pseudomonas syringae} |
268 | 4L68_B | 340 | 255 | 100.0 | 5.7E-34 | [------------ ] | Leucine-rich repeat protein kinase-like protein; pseudokinase, negative immune regulator, SIGNALING; HET: PDO; 2.0A {Arabidopsis thaliana} |
269 | 4I93_A | 300 | 245 | 100.0 | 7.2E-34 | [------------ ] | Probable serine/threonine-protein kinase At5g41260 (E.C.2.7.11.1); Protein kinase, Pseudo kinase, CFG; 1.5A {Arabidopsis thaliana} |
270 | 4WB8_A | 337 | 234 | 100.0 | 1.6E-33 | [----------- ] | cAMP-dependent protein kinase A (catalytic; catalysis, protein kinase, adenosine triphosphate; HET: ATP, TPO, MES, SEP; 1.55A {Homo sapiens} |
271 | 3F69_B | 311 | 246 | 100.0 | 8.3E-34 | [----------- ] | Serine/threonine-protein kinase pknB (E.C.2.7.11.1); protein kinase, PknB, Mycobacterium tuberculosis; HET: XDR, SO4; 2.8A {Mycobacterium tuberculosis} |
272 | 1RDQ_E | 350 | 234 | 100.0 | 1.2E-33 | [----------- ] | cAMP-dependent protein kinase, alpha-catalytic subunit; cAMP-dependent protein kinase,catalytic mechanism, ATP; HET: ADP, ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 |
273 | 4IX3_B | 350 | 263 | 100.0 | 1.4E-33 | [------------ ] | MsStt7d protein; protein kinase, canonical protein kinase; 1.35A {Micromonas} |
274 | 3UGC_A | 295 | 252 | 100.0 | 5.7E-34 | [------------ ] | Tyrosine-protein kinase JAK2 (E.C.2.7.10.2); Small molecule inhibitor, ATP Binding; HET: 046; 1.34A {Homo sapiens} |
275 | 5GNK_A | 297 | 250 | 100.0 | 9.9E-34 | [------------ ] | Epidermal growth factor receptor (E.C.2.7.10.1); EGFR, T790M, LXX-6-34, inhibitor, TRANSFERASE; HET: 80U, EDO, NO3; 1.796A {Homo sapiens} |
276 | 5DBX_B | 328 | 256 | 100.0 | 5.8E-34 | [------------ ] | STE20/SPS1-related proline-alanine-rich protein kinase (E.C.2.7.11.1); Kinase, TRANSFERASE; HET: CAS, ANP; 2.5A {Mus musculus} |
277 | 3GC0_A | 329 | 258 | 100.0 | 8.6E-34 | [------------ ] | Kinase, CMGC CDK; SSGCID, Kinase, CMGC CDK, AMP; HET: AMP; 2.0A {Giardia lamblia} |
278 | 3ZON_A | 335 | 246 | 100.0 | 1.3E-33 | [------------ ] | NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2 (E.C.2.7.11.1; TRANSFERASE, JAK; HET: IK1; 2.15A {HOMO SAPIENS} |
279 | 4ZP5_B | 309 | 241 | 100.0 | 2.1E-33 | [----------- ] | Mitogen-activated protein kinase kinase kinase; kinase, inhibitor, TRANSFERASE-INHIBITOR complex; HET: 4QG; 2.29A {Homo sapiens} |
280 | 3GBZ_A | 329 | 258 | 100.0 | 7.4E-34 | [------------ ] | Kinase, CMGC CDK; SSGCID, Kinase, CMGC CDK, ATP-binding; 1.85A {Giardia lamblia} |
281 | 1FVR_A | 327 | 248 | 100.0 | 1.4E-33 | [------------ ] | TYROSINE-PROTEIN KINASE TIE-2 (E.C.2.7.1.112); tyrosine kinase, TRANSFERASE; 2.2A {Homo sapiens} SCOP: d.144.1.7 |
282 | 4C57_A | 340 | 257 | 100.0 | 3.2E-33 | [------------ ] | CYCLIN-G-ASSOCIATED KINASE (E.C.2.7.11.1), NANOBODY; TRANSFERASE, KINASE, CONFORMATIONAL PLASTICITY, ACTIVATION; HET: EDO, FEF, SO4; 2.55A {HOMO SAPIENS} |
283 | 4YZC_A | 405 | 251 | 100.0 | 6.1E-34 | [------------ ] | Serine/threonine-protein kinase/endoribonuclease IRE1; IRE1, inhibitor, staurosporine, complex, Transferase-transferase; HET: SEP, STU; 2.494A {Homo sapiens} |
284 | 4G31_A | 299 | 247 | 100.0 | 4.5E-34 | [----------- ] | Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic; HET: 0WH; 2.28A {Homo sapiens} |
285 | 1OB3_A | 288 | 244 | 100.0 | 3.7E-34 | [----------- ] | CELL DIVISION CONTROL PROTEIN 2; TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, PHOSPHORYLATION; 1.9A {PLASMODIUM FALCIPARUM} SCOP: d.144.1.7 |
286 | 3W32_A | 330 | 250 | 100.0 | 8.8E-34 | [------------ ] | Epidermal growth factor receptor (E.C.2.7.10.1); ANTI-ONCOGENE, CELL CYCLE, DISEASE MUTATION; HET: W32; 1.8A {Homo sapiens} |
287 | 2OWB_A | 335 | 248 | 100.0 | 3.4E-33 | [------------ ] | Serine/threonine-protein kinase PLK1 (E.C.2.7.11.21); Catalytic domain, plk1, polo-like kinase1; HET: 626; 2.1A {Homo sapiens} |
288 | 3PPZ_B | 309 | 251 | 100.0 | 4.1E-33 | [------------ ] | Serine/threonine-protein kinase CTR1 (E.C.2.7.11.1); Kinase, ATP binding, Phosphorylation, TRANSFERASE; HET: STU; 2.99A {Arabidopsis thaliana} |
289 | 4UXL_A | 322 | 252 | 100.0 | 3.9E-33 | [------------ ] | PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS (E.C.2.7.10.1); TRANSFERASE, INHIBITOR, ROS; HET: 5P8; 2.4A {HOMO SAPIENS} |
290 | 2W5B_A | 279 | 248 | 100.0 | 2.1E-33 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE NEK2 (E.C.2.7.11.1); TRANSFERASE, MEIOSIS, MITOSIS, METAL-BINDING, PHOSPHOPROTEIN; HET: AGS; 2.4A {HOMO SAPIENS} |
291 | 4WOT_B | 396 | 251 | 100.0 | 6.3E-34 | [------------ ] | HUMAN RHO-KINASE2; TRANSFERASE; HET: 3SG; 2.93A {N/A} |
292 | 1FMK_A | 452 | 245 | 100.0 | 1.7E-33 | [------------ ] | TYROSINE-PROTEIN KINASE SRC; SRC, TYROSINE KINASE, PHOSPHORYLATION, SH2; 1.5A {Homo sapiens} SCOP: d.93.1.1, b.34.2.1, d.144.1.7 |
293 | 3ZBF_A | 322 | 252 | 100.0 | 3.8E-33 | [------------ ] | PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS (E.C.2.7.10.1); TRANSFERASE, TYROSINE KINASE; HET: VGH; 2.2A {HOMO SAPIENS} |
294 | 3N9X_B | 432 | 259 | 100.0 | 3.6E-33 | [------------ ] | Phosphotransferase; malaria kinase, Structural Genomics, Structural; HET: GOL; 2.05A {Plasmodium berghei} |
295 | 2VD5_A | 412 | 253 | 100.0 | 9.9E-34 | [------------ ] | DMPK PROTEIN (E.C.2.7.11.1); SERINE/THREONINE-PROTEIN KINASE, KINASE, TRANSFERASE, ATP-BINDING; HET: BI8; 2.8A {HOMO SAPIENS} |
296 | 1Y57_A | 452 | 246 | 100.0 | 1.7E-33 | [------------ ] | Proto-oncogene tyrosine-protein kinase Src (E.C.2.7.1.112); Kinase structure, SH3, SH2, TRANSFERASE; HET: SO4, MPZ; 1.91A {Homo sapiens} SCOP: d.93.1.1, d.144.1.7, b.34.2.1 |
297 | 3NYV_A | 484 | 245 | 100.0 | 1.3E-33 | [----------- ] | Calmodulin-domain protein kinase 1 (E.C.2.7.11.17); serine/threonine protein kinase, transferase, calcium-binding; HET: DTQ; 1.88A {Toxoplasma gondii} |
298 | 4YC3_A | 302 | 245 | 100.0 | 2.4E-33 | [----------- ] | Cyclin-dependent kinase 1 (E.C.2.7.11.22,2.7.11.23), G2/mitotic-specific; CDK1, Cyclin B1, CKS2, Cell; HET: MPD; 2.7A {Homo sapiens} |
299 | 4RED_B | 351 | 240 | 100.0 | 4.1E-34 | [----------- ] | 5'-AMP-activated protein kinase catalytic subunit; Kinase Domain Fold, phosphorylate numerous; 2.95A {Homo sapiens} |
300 | 3UTO_B | 573 | 256 | 100.0 | 3.9E-33 | [------------ ] | Twitchin (E.C.2.7.11.1); kinase, muscle sarcomere, TRANSFERASE; HET: FLC, P33; 2.4A {Caenorhabditis elegans} |
301 | 4O0V_A | 293 | 239 | 100.0 | 1.6E-33 | [----------- ] | Serine/threonine-protein kinase PAK 4 (E.C.2.7.11.1); PAK4, transferase-transferase inhibitor complex; HET: 2OL; 2.8A {Homo sapiens} |
302 | 4B9D_B | 350 | 241 | 100.0 | 4.2E-33 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE NEK1 (E.C.2.7.11.1); TRANSFERASE, INHIBITOR; HET: CK7; 1.9A {HOMO SAPIENS} |
303 | 4APC_B | 350 | 241 | 100.0 | 4.2E-33 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE NEK1 (E.C.2.7.11.1); TRANSFERASE; 2.1A {HOMO SAPIENS} |
304 | 3Q4U_B | 301 | 251 | 100.0 | 1.9E-33 | [------------ ] | Activin receptor type-1 (E.C.2.7.11.30); Structural Genomics Consortium, SGC, Protein; HET: FLC, LDN, EDO; 1.82A {Homo sapiens} |
305 | 4ZZN_A | 350 | 255 | 100.0 | 4E-33 | [------------ ] | MITOGEN-ACTIVATED PROTEIN KINASE 1 (E.C.2.7.11.24); TRANSFERASE; HET: CME, SO4, CQ8; 1.33A {HOMO SAPIENS} |
306 | 4YZ9_A | 405 | 250 | 100.0 | 1.1E-33 | [------------ ] | Serine/threonine-protein kinase/endoribonuclease IRE1; active, inhibitor, complex, IRE1, TRANSFERASE-TRANSFERASE; HET: 4K7; 2.463A {Homo sapiens} |
307 | 5KBQ_A | 289 | 238 | 100.0 | 8.8E-33 | [----------- ] | Serine/threonine-protein kinase PAK 1 (E.C.2.7.11.1); Serine/threonine-protein kinase PAK1, KINASE, TRANSFERASE; HET: IPV; 2.58A {Homo sapiens} |
308 | 4CZT_D | 464 | 243 | 100.0 | 2E-33 | [----------- ] | CBL-INTERACTING SERINE/THREONINE-PROTEIN KINASE 23 (E.C.2.7.11.1); TRANSFERASE, POTASSIUM TRANSPORT, SNRK3; HET: CPS, SO4; 2.3A {ARABIDOPSIS THALIANA} |
309 | 5LI9_A | 350 | 239 | 100.0 | 8.1E-33 | [----------- ] | Protein kinase C iota type; aPKC, Polarity, Complex, transferase; HET: ACP, TPO, PEG, FMT; 1.79A {Homo sapiens} |
310 | 2J0L_A | 276 | 247 | 100.0 | 4.9E-33 | [------------ ] | FOCAL ADHESION KINASE 1 (E.C.2.7.10.2); FOCAL ADHESION, CELL MIGRATION, PHOSPHORYLATION; HET: ANP; 2.3A {GALLUS GALLUS} |
311 | 4CZU_A | 464 | 244 | 100.0 | 1.9E-33 | [----------- ] | CBL-INTERACTING SERINE/THREONINE-PROTEIN KINASE 23 (E.C.2.7.11.1); TRANSFERASE, POTASSIUM TRANSPORT, SNRK3; HET: CPS, SO4; 1.9A {ARABIDOPSIS THALIANA} |
312 | 5UY6_A | 291 | 242 | 100.0 | 1.3E-33 | [----------- ] | BMP-2-inducible protein kinase (E.C.2.7.11.1); transferase, protein kinase domain, Structural; HET: 8R4; 1.7A {Homo sapiens} |
313 | 2XRW_A | 371 | 258 | 100.0 | 3.2E-33 | [------------ ] | MITOGEN-ACTIVATED PROTEIN KINASE 8 (E.C.2.7.11.24); TRANSCRIPTION, MAPK SIGNALING PATHWAYS, LINEAR; HET: GOL, ANP; 1.33A {HOMO SAPIENS} |
314 | 4Y0X_A | 375 | 225 | 100.0 | 2.8E-34 | [----------- ] | S/T protein kinase PknG from; S/T protein kinase, PknG, transferase; HET: ADP; 1.74A {Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)} |
315 | 2JAM_B | 304 | 251 | 100.0 | 9.7E-34 | [------------ ] | CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1G; TRANSFERASE, KINASE, MEMBRANE, ATP-BINDING, PRENYLATION; HET: J60, EDO; 1.7A {UNIDENTIFIED} |
316 | 2JAM_A | 304 | 251 | 100.0 | 9.7E-34 | [------------ ] | CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 1G; TRANSFERASE, KINASE, MEMBRANE, ATP-BINDING, PRENYLATION; HET: J60, EDO; 1.7A {UNIDENTIFIED} |
317 | 4IX3_A | 350 | 253 | 100.0 | 5.2E-33 | [----------- ] | MsStt7d protein; protein kinase, canonical protein kinase; 1.35A {Micromonas} |
318 | 3F2A_A | 300 | 237 | 100.0 | 6.2E-34 | [----------- ] | Proto-oncogene serine/threonine-protein kinase Pim-1 (E.C.2.7.11.1); potein kinase fold, Alternative initiation; HET: 985; 1.9A {Homo sapiens} |
319 | 4FR4_A | 384 | 238 | 100.0 | 2.8E-33 | [----------- ] | Serine/threonine-protein kinase 32A (E.C.2.7.11.1); Structural Genomics, Structural Genomics Consortium; HET: EDO, STU; 2.29A {Homo sapiens} |
320 | 1J1B_A | 420 | 241 | 100.0 | 1.3E-33 | [----------- ] | Glycogen synthase kinase-3 beta(E.C.2.7.1.37); complex, tau, kinase, AMPPNP, TRANSFERASE; HET: ANP; 1.8A {Homo sapiens} SCOP: d.144.1.7 |
321 | 3FXZ_A | 297 | 240 | 100.0 | 9.6E-33 | [----------- ] | Serine/threonine-protein kinase PAK 1 (E.C.2.7.11.1); Transferase, Kinase, ATP-binding, Phosphorylation, Allosteric; HET: FLL; 1.64A {Homo sapiens} |
322 | 4WIH_A | 353 | 234 | 100.0 | 4.5E-33 | [----------- ] | cAMP-dependent protein kinase catalytic subunit; PKA, Kinase, Serine/threonine-protein kinase, Transferase; HET: TPO, SEP; 1.139A {Cricetulus griseus} |
323 | 5B2L_A | 324 | 248 | 100.0 | 3.4E-33 | [------------ ] | Dual specificity mitogen-activated protein kinase; protein kinase, mutation, Apo structure; HET: EPE; 2.1A {Homo sapiens} |
324 | 4I94_B | 300 | 245 | 100.0 | 7.2E-34 | [------------ ] | Probable serine/threonine-protein kinase At5g41260 (E.C.2.7.11.1); Protein kinase, Pseudo kinase, CFG; HET: ANP; 1.8A {Arabidopsis thaliana} |
325 | 5LOH_B | 341 | 262 | 100.0 | 4.5E-33 | [------------ ] | Serine/threonine-protein kinase greatwall,Greatwall (E.C.2.7.11.1,2.7.11.1); Kinase domain, Inhibitor, transferase; HET: STU, EDO; 3.1A {Homo sapiens} |
326 | 5AJQ_A | 295 | 247 | 100.0 | 3.5E-33 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE 10 (E.C.2.7.11.1); TRANSFERASE; HET: DB8; 2.2A {HOMO SAPIENS} |
327 | 3R04_A | 299 | 237 | 100.0 | 5E-34 | [----------- ] | Proto-oncogene serine/threonine-protein kinase pim-1 (E.C.2.7.11.1); kinae, pim1, inhibitor, TRANSFERASE-TRANSFERASE INHIBITOR; HET: UNQ, IMD; 1.7A {Homo sapiens} |
328 | 3SV0_A | 483 | 261 | 100.0 | 1.3E-33 | [------------ ] | Casein kinase I-like; kinase, Typical kinase domain fold; 2.0A {Oryza sativa Japonica Group} |
329 | 5JZJ_B | 297 | 243 | 100.0 | 1.3E-33 | [----------- ] | Serine/threonine-protein kinase DCLK1 (E.C.2.7.11.1); kinase, doublecortin, TRANSFERASE; HET: AN2; 1.71A {Homo sapiens} |
330 | 3UIM_A | 326 | 254 | 100.0 | 1.2E-33 | [------------ ] | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase; kinase, protein kinase, TRANSFERASE; HET: ANP; 2.2A {Arabidopsis thaliana} |
331 | 4L68_A | 340 | 255 | 100.0 | 2.8E-33 | [------------ ] | Leucine-rich repeat protein kinase-like protein; pseudokinase, negative immune regulator, SIGNALING; HET: PDO; 2.0A {Arabidopsis thaliana} |
332 | 5LOH_A | 341 | 262 | 100.0 | 4.5E-33 | [------------ ] | Serine/threonine-protein kinase greatwall,Greatwall (E.C.2.7.11.1,2.7.11.1); Kinase domain, Inhibitor, transferase; HET: EDO, STU; 3.1A {Homo sapiens} |
333 | 2UZV_A | 336 | 234 | 100.0 | 5.1E-33 | [----------- ] | CAMP-DEPENDENT PROTEIN KINASE INHIBITOR ALPHA; CAMP, KINASE, MYRISTATE, TRANSFERASE, LIPOPROTEIN; HET: SS5; 2.5A {BOS TAURUS} |
334 | 3H4J_A | 336 | 240 | 100.0 | 1.5E-33 | [----------- ] | SNF1-like protein kinase ssp2 (E.C.2.7.11.1); AMPK, kinase, ATP-binding, Nucleotide-binding, Phosphoprotein; 2.8A {Schizosaccharomyces pombe} |
335 | 4Y12_A | 375 | 225 | 100.0 | 4.2E-34 | [----------- ] | S/T protein kinase PknG from; S/T protein kinase, PknG, transferase; HET: AGS; 1.9A {Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)} |
336 | 4LQQ_A | 508 | 250 | 100.0 | 9.8E-34 | [----------- ] | Serine/threonine-protein kinase CBK1 (E.C.2.7.11.1), CBK1; Kinase, TRANSFERASE-TRANSFERASE activator complex; HET: ANP; 3.6A {Saccharomyces cerevisiae} |
337 | 2W5A_A | 279 | 245 | 100.0 | 3.7E-33 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE NEK2 (E.C.2.7.11.1); SER/THR PROTEIN KINASE, KINASE, NUCLEUS; HET: EDO, ADP; 1.55A {HOMO SAPIENS} |
338 | 2YCF_A | 322 | 245 | 100.0 | 3.3E-33 | [----------- ] | SERINE/THREONINE-PROTEIN KINASE CHK2 (E.C.2.7.11.1); TRANSFERASE, ANTICANCER, ANTICANCER DRUG DESIGN; HET: YCF; 1.77A {HOMO SAPIENS} |
339 | 2IWI_B | 312 | 246 | 100.0 | 1.8E-33 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE PIM-2 (E.C.2.7.11.1); NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, PIM2, KINASE; HET: HB1; 2.8A {HOMO SAPIENS} |
340 | 4X7Q_A | 312 | 245 | 100.0 | 2.7E-33 | [------------ ] | Serine/threonine-protein kinase pim-2; TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: 3YR; 2.33A {Homo sapiens} |
341 | 3V8S_C | 410 | 252 | 100.0 | 2.1E-33 | [------------ ] | Rho-associated protein kinase 1 (E.C.2.7.11.1); KINASE, DIMERIZATION, MYOSIN, TRANSFERASE, INHIBITOR; HET: 0HD; 2.286A {Homo sapiens} |
342 | 3EB0_A | 383 | 245 | 100.0 | 3.8E-33 | [------------ ] | Crystal Structure of cgd4_240 from; kinase cryptosporidium parvum, ATP-binding, Kinase; HET: GOL, DRK; 2.65A {Cryptosporidium parvum Iowa II} |
343 | 2FST_X | 367 | 252 | 100.0 | 1.9E-33 | [------------ ] | Mitogen-activated protein kinase 14 (E.C.2.7.1.37); mitogen activated protein kinase, p38; HET: BOG; 1.45A {Homo sapiens} |
344 | 5E8X_A | 307 | 252 | 100.0 | 3.6E-33 | [------------ ] | TGF-beta receptor type-1 (E.C.2.7.11.30); ALK5, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR; HET: STU; 1.45A {Homo sapiens} |
345 | 5USQ_A | 299 | 254 | 100.0 | 2.9E-33 | [------------ ] | TGF-beta receptor type-1 (E.C.2.7.11.30); TGF-beta receptor type I, Serine/threonine-protein; HET: 8LY; 2.55A {Homo sapiens} |
346 | 5V62_A | 351 | 246 | 100.0 | 1.4E-32 | [----------- ] | Mitogen-activated protein kinase 1 (E.C.2.7.11.24); kinase, MAPK, phosphorylation, cancer, TRANSFERASE; HET: PTR, GOL, FRZ, TPO; 1.9A {Homo sapiens} |
347 | 3SLS_B | 304 | 237 | 100.0 | 6.2E-33 | [----------- ] | Dual specificity mitogen-activated protein kinase; Serine-threonine kinase, Signalling, TRANSFERASE-TRANSFERASE INHIBITOR; HET: 77D, ANP; 2.3A {Homo sapiens} |
348 | 3LLT_A | 360 | 244 | 100.0 | 9.2E-33 | [----------- ] | Serine/threonine kinase-1, PfLammer; lammer kinase, malaria, plasmodium falciparum; HET: ANP; 2.5A {Plasmodium falciparum 3D7} |
349 | 1RJB_A | 344 | 251 | 100.0 | 5.3E-33 | [------------ ] | FL cytokine receptor (E.C.2.7.1.112); Kinase, Autoinhibition, Juxtamembrane domain, TRANSFERASE; 2.1A {Homo sapiens} SCOP: d.144.1.7 |
350 | 5EI6_A | 313 | 256 | 100.0 | 1.1E-32 | [------------ ] | Monopolar Spindle kinase 1 (MPS1); Spindle Assembly Checkpoint (SAC), Oncology; HET: 5OQ; 2.01A {Homo sapiens} |
351 | 1ZZL_A | 351 | 251 | 100.0 | 7.1E-33 | [------------ ] | Mitogen-activated protein kinase 14 (E.C.2.7.1.37); Phosphorylation,Serine/threonine-protein kinase, Transferase; HET: TZY; 2.0A {Homo sapiens} SCOP: d.144.1.7 |
352 | 4L00_B | 304 | 253 | 100.0 | 1.3E-32 | [------------ ] | Tyrosine-protein kinase JAK1 (E.C.2.7.10.2); kinase domain fold, regulatory, TRANSFERASE; 1.8A {Homo sapiens} |
353 | 2A1A_B | 284 | 239 | 100.0 | 1.9E-33 | [------------ ] | Eukaryotic translation initiation factor 2; transferase, kinase, protein biosynthesis, protein; 2.8A {Saccharomyces cerevisiae} |
354 | 3FBV_D | 448 | 249 | 100.0 | 4.4E-33 | [----------- ] | Serine/threonine-protein kinase/endoribonuclease IRE1 (E.C.2.7.11.1, 3.1.26.-); IRE1, RNase, ribonuclease, complex, kinase; HET: APJ; 3.2A {Saccharomyces cerevisiae} |
355 | 2WTK_C | 305 | 250 | 100.0 | 7.6E-33 | [------------ ] | CALCIUM-BINDING PROTEIN 39, STE20-RELATED KINASE; TRANSFERASE-METAL-BINDING PROTEIN COMPLEX, TRANSFERASE METAL-BINDING; HET: ANP; 2.65A {HOMO SAPIENS} |
356 | 5J1V_A | 339 | 243 | 100.0 | 2.2E-32 | [----------- ] | Dual specificity protein kinase CLK1; Transferase, SERINE/THREONINE-PROTEIN KINASE, TYROSINE-PROTEIN KINASE; HET: GOL, 6FD; 2.52A {Homo sapiens} |
357 | 4W8D_A | 290 | 238 | 100.0 | 9.7E-33 | [----------- ] | Serine-threonine-protein kinase 24 (E.C.2.7.11.1); MST3, Pyrrolopyrimidine, Kinase, inhibitor, transferase-transferase; HET: TPO, 3JA; 1.77A {Homo sapiens} |
358 | 4ALW_A | 328 | 236 | 100.0 | 1.8E-33 | [----------- ] | PIM-1 KINASE (E.C.2.7.1.37); TRANSFERASE, PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1; HET: HY7, IMD; 1.92A {HOMO SAPIENS} |
359 | 3P86_A | 309 | 248 | 100.0 | 1.4E-32 | [------------ ] | Serine/threonine-protein kinase CTR1 (E.C.2.7.11.1); kinase, ETR1, ERS1, ETR2, Phosphorylation; HET: STU; 2.496A {Arabidopsis thaliana} |
360 | 4QPM_A | 356 | 252 | 100.0 | 3.1E-33 | [------------ ] | Mitotic checkpoint serine/threonine-protein kinase BUB1; Transferase; HET: ADP; 2.202A {Homo sapiens} |
361 | 4KRC_A | 317 | 245 | 100.0 | 7E-33 | [----------- ] | Cyclin-dependent protein kinase PHO85 (E.C.2.7.11.22); Glycogen Synthesis, Glycogen Synthesis Regulation; HET: AGS; 2.597A {Saccharomyces cerevisiae} |
362 | 4KRD_A | 317 | 245 | 100.0 | 6.1E-33 | [----------- ] | Cyclin-dependent protein kinase PHO85 (E.C.2.7.11.22); Glycogen Synthesis, CDK, cyclin, Glycogen; 1.952A {Saccharomyces cerevisiae} |
363 | 5UYJ_A | 291 | 241 | 100.0 | 2.7E-33 | [----------- ] | Calcium/calmodulin-dependent protein kinase kinase 2; transferase, protein kinase domain, Structural; HET: 8R7; 1.6A {Homo sapiens} |
364 | 2WTK_F | 305 | 249 | 100.0 | 4.6E-33 | [------------ ] | CALCIUM-BINDING PROTEIN 39, STE20-RELATED KINASE; TRANSFERASE-METAL-BINDING PROTEIN COMPLEX, TRANSFERASE METAL-BINDING; HET: ANP; 2.65A {HOMO SAPIENS} |
365 | 4AN3_A | 301 | 237 | 100.0 | 6E-34 | [----------- ] | DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE; TRANSFERASE, MAP2K1, ATP-BINDING, ALLOSTERIC INHIBITION; HET: ATP, 5Y0; 2.1A {HOMO SAPIENS} |
366 | 2CSN_A | 297 | 261 | 100.0 | 4.8E-33 | [------------ ] | CASEIN KINASE-1, N-(2-AMINOETHYL)-5-CHLOROISOQUINOLINE-8-SULFONAMIDE; CASEIN KINASE-1, PROTEIN KINASE; HET: CKI, SO4; 2.5A {Schizosaccharomyces pombe} SCOP: d.144.1.7 |
367 | 3Q4U_D | 301 | 251 | 100.0 | 1.9E-33 | [------------ ] | Activin receptor type-1 (E.C.2.7.11.30); Structural Genomics Consortium, SGC, Protein; HET: FLC, EDO, LDN; 1.82A {Homo sapiens} |
368 | 3LIJ_A | 494 | 255 | 100.0 | 1.4E-32 | [------------ ] | Calcium/calmodulin dependent protein kinase with; Transferase, calcium dependent protein kinase; HET: ANP; 1.9A {Cryptosporidium parvum} |
369 | 5VDK_A | 297 | 241 | 100.0 | 5.4E-33 | [----------- ] | Wee1-like protein kinase 2 (E.C.2.7.10.2); KINASE DOMAIN, CELL CYCLE, WEE2; HET: 8X7, PO4; 2.7A {Homo sapiens} |
370 | 3IS5_D | 285 | 243 | 100.0 | 2.2E-32 | [----------- ] | Calcium-dependent protein kinase (E.C.2.7.11.17); toxoplasma gondii, cdpk, structural genomics; HET: GOL, ANP; 2.55A {Toxoplasma gondii} |
371 | 2BUJ_A | 317 | 258 | 100.0 | 6.1E-33 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE 16 (E.C.2.7.1.37); TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE; HET: STU; 2.6A {HOMO SAPIENS} |
372 | 5ITA_B | 297 | 252 | 100.0 | 3.6E-32 | [------------ ] | Serine/threonine-protein kinase B-raf (E.C.2.7.11.1); transferase, kinase and inhibitor complex; HET: 6DC; 1.95A {Homo sapiens} |
373 | 5CEK_A | 263 | 241 | 100.0 | 8E-33 | [------------ ] | Tribbles homolog 1; kinase, TRANSFERASE; 2.8A {Homo sapiens} |
374 | 1V0B_A | 288 | 244 | 100.0 | 1.7E-33 | [----------- ] | CELL DIVISION CONTROL PROTEIN 2; TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, PHOSPHORYLATION; 2.2A {PLASMODIUM FALCIPARUM} SCOP: d.144.1.7 |
375 | 3H4J_B | 336 | 240 | 100.0 | 9.8E-34 | [----------- ] | SNF1-like protein kinase ssp2 (E.C.2.7.11.1); AMPK, kinase, ATP-binding, Nucleotide-binding, Phosphoprotein; 2.8A {Schizosaccharomyces pombe} |
376 | 1BLX_A | 326 | 260 | 100.0 | 7.4E-33 | [------------ ] | CYCLIN-DEPENDENT KINASE 6, P19INK4D; INHIBITOR PROTEIN, CYCLIN-DEPENDENT KINASE, CELL; 1.9A {Homo sapiens} SCOP: d.144.1.7 |
377 | 5HES_A | 307 | 239 | 100.0 | 2.6E-33 | [------------ ] | Mitogen-activated protein kinase kinase kinase; Kinase, Complex, transferase; HET: 032, TPO; 2.14A {Homo sapiens} |
378 | 1ZY4_B | 303 | 255 | 100.0 | 5.8E-33 | [------------ ] | Serine/threonine-protein kinase GCN2 (E.C.2.7.1.37); TRANSLATION REGULATOR, PROTEIN KINASE, SIGNAL; HET: GOL; 1.95A {Saccharomyces cerevisiae} |
379 | 4Y5Q_A | 486 | 250 | 100.0 | 2.6E-32 | [------------ ] | CpCDPK1 (E.C.2.7.11.17); serine/threonine protein kinase, transferase, calcium-binding; HET: AMP; 2.0A {Cryptosporidium parvum Iowa II} |
380 | 4YSM_B | 491 | 252 | 100.0 | 3.8E-32 | [------------ ] | EtCDPK1 (E.C.2.7.11.17); serine/threonine protein kinase, transferase, calcium-binding; 3.19A {Eimeria tenella} |
381 | 3COM_B | 314 | 240 | 100.0 | 3.3E-32 | [----------- ] | Serine/threonine-protein kinase 4 (E.C.2.7.11.1); kinase, Mst1, Serine/threonine-protein kinase 4; 2.2A {Homo sapiens} |
382 | 2EU9_A | 355 | 245 | 100.0 | 1.3E-32 | [----------- ] | Dual specificity protein kinase CLK3; kinase domain, TRANSFERASE; 1.53A {Homo sapiens} |
383 | 3MWU_A | 486 | 244 | 100.0 | 3E-32 | [----------- ] | Calmodulin-domain protein kinase 1 (E.C.2.7.11.17); serine/threonine protein kinase, transferase, calcium-binding; HET: BK3; 1.98A {Cryptosporidium parvum} |
384 | 3A7I_A | 303 | 237 | 100.0 | 2.9E-32 | [----------- ] | Serine/threonine kinase 24 (STE20 homolog; two-lobe protein kinase fold, ATP-binding; HET: ADE; 1.45A {Homo sapiens} |
385 | 3OZ6_B | 388 | 252 | 100.0 | 2.1E-32 | [----------- ] | Mitogen-activated protein kinase 1, serine/threonine; Structural Genomics Consortium, SGC, kinase; 2.37A {Cryptosporidium parvum Iowa II} |
386 | 1Z57_A | 339 | 243 | 100.0 | 3.3E-32 | [----------- ] | Dual specificity protein kinase CLK1; protein tyrosine kinase, dual specificity; HET: DBQ; 1.7A {Homo sapiens} |
387 | 4O38_B | 338 | 256 | 100.0 | 8.7E-33 | [------------ ] | Cyclin-G-associated kinase (E.C.2.7.11.1); Structural Genomics, Structural Genomics Consortium; HET: GOL, SIN; 2.097A {Homo sapiens} |
388 | 3Q04_A | 328 | 239 | 100.0 | 8.3E-33 | [----------- ] | Casein kinase II subunit alpha; protein kinase, apo-form, TRANSFERASE; HET: SO4; 1.8A {Homo sapiens} |
389 | 4O2Z_A | 377 | 255 | 100.0 | 2.7E-32 | [------------ ] | Mitogen-activated protein kinase 3, putative; neglected disease, Structural Genomics, Structural; HET: 046; 2.71A {Leishmania donovani} |
390 | 2A19_C | 284 | 239 | 100.0 | 1.9E-33 | [------------ ] | Eukaryotic translation initiation factor 2; transferase, kinase, protein biosynthesis, protein; HET: ANP; 2.5A {Saccharomyces cerevisiae} |
391 | 4NFN_A | 309 | 254 | 100.0 | 2.3E-32 | [------------ ] | Tau-tubulin kinase 1 (E.C.2.7.11.1); protein kinase, phosphotransferase, TRANSFERASE-TRANSFERASE INHIBITOR; HET: SO4, 2KC; 1.42A {Homo sapiens} |
392 | 3AN0_A | 340 | 241 | 100.0 | 9.8E-33 | [----------- ] | Dual specificity mitogen-activated protein kinase; auto inhibition state, activation helix; HET: ANK; 2.6A {Homo sapiens} |
393 | 3OZ6_A | 388 | 251 | 100.0 | 2.2E-32 | [----------- ] | Mitogen-activated protein kinase 1, serine/threonine; Structural Genomics Consortium, SGC, kinase; 2.37A {Cryptosporidium parvum Iowa II} |
394 | 4AW2_A | 437 | 253 | 100.0 | 1.2E-32 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE MRCK ALPHA (E.C.2.7.11.1); TRANSFERASE, CDC42BPA; HET: 22E, EDO; 1.7A {RATTUS NORVEGICUS} |
395 | 3LM0_A | 327 | 246 | 100.0 | 1.1E-32 | [----------- ] | Serine/threonine-protein kinase 17B (E.C.2.7.11.1); STK17B, serine/threonine kinase 17B, DRAK2; HET: EBD; 2.35A {Homo sapiens} |
396 | 5E8V_A | 316 | 254 | 100.0 | 1.4E-32 | [------------ ] | TGF-beta receptor type-2 (E.C.2.7.11.30); KINASE DOMAIN, TRANSFERASE; 1.69A {Homo sapiens} |
397 | 3PG1_A | 362 | 254 | 100.0 | 2.6E-32 | [------------ ] | Mitogen-activated protein kinase, putative (Map; ePK ser/thr protein kinase fold; 1.95A {Leishmania major} |
398 | 3IS5_F | 285 | 244 | 100.0 | 2.5E-32 | [----------- ] | Calcium-dependent protein kinase (E.C.2.7.11.17); toxoplasma gondii, cdpk, structural genomics; HET: GOL, ANP; 2.55A {Toxoplasma gondii} |
399 | 3LXP_A | 318 | 249 | 100.0 | 7.9E-32 | [------------ ] | Non-receptor tyrosine-protein kinase TYK2 (E.C.2.7.10.2); TYK2, JAK3, inflammation, cancer, PAN; HET: IZA; 1.65A {Homo sapiens} |
400 | 3UDB_D | 317 | 243 | 100.0 | 1.2E-32 | [----------- ] | Serine/threonine-protein kinase SRK2E (E.C.2.7.11.1); SnRK2.6, kinase, ABA signaling pathway; 2.567A {Arabidopsis thaliana} |
401 | 5CEM_A | 292 | 241 | 100.0 | 1.5E-32 | [------------ ] | Tribbles homolog 1; Kinase, Kinase-like, TRANSFERASE; HET: SO4; 2.1A {Homo sapiens} |
402 | 4RLK_A | 332 | 238 | 100.0 | 6.5E-32 | [----------- ] | Casein kinase II subunit alpha; TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: GOL, E91; 1.24A {Zea mays} |
403 | 5LPB_A | 296 | 246 | 100.0 | 4E-33 | [----------- ] | Protein BRASSINOSTEROID INSENSITIVE 1 (E.C.2.7.10.1,2.7.11.1); brassinosteroid receptor, kinase domain, dual-specificify; HET: TPO, SEP, ADP; 1.98A {Arabidopsis thaliana} |
404 | 5LPY_A | 296 | 248 | 100.0 | 4.4E-33 | [----------- ] | Protein BRASSINOSTEROID INSENSITIVE 1 (E.C.2.7.10.1,2.7.11.1); brassinosteroid receptor, kinase domain, dual-specificify; HET: ATP, TPO, SEP; 2.3A {Arabidopsis thaliana} |
405 | 4M66_B | 325 | 255 | 100.0 | 4.4E-33 | [------------ ] | Receptor-interacting serine/threonine-protein kinase 3 (E.C.2.7.11.1); kinase, protein phosphorylation, Transferase; 2.401A {Mus musculus} |
406 | 3LM5_A | 327 | 246 | 100.0 | 1.1E-32 | [----------- ] | ---; STK17B, serine/threonine kinase 17B, DRAK2; HET: QUE; 2.29A {Homo sapiens} |
407 | 4TND_A | 590 | 242 | 100.0 | 7.4E-33 | [----------- ] | G Protein-Coupled Receptor Kinase 5; GRK5-(5-Adenylylimidodiphosphate) complex, GRK5-(AMP-PNP) complex, GPCR; HET: ANP; 1.802A {Homo sapiens} |
408 | 2W1Z_B | 368 | 236 | 100.0 | 4.5E-34 | [----------- ] | ROP2 (E.C.2.7.-.-); INACTIVITY, PROTEIN-KINASE, MEMBRANE-ATTACHMENT, TRANSFERASE; HET: SO4; 1.97A {TOXOPLASMA GONDII} |
409 | 5CEN_A | 300 | 244 | 100.0 | 4.1E-33 | [------------ ] | Mitogen-activated protein kinase kinase kinase; kinase, TRANSFERASE; 1.7A {Homo sapiens} |
410 | 5E92_A | 316 | 254 | 100.0 | 1.4E-32 | [------------ ] | TGF-beta receptor type-2 (E.C.2.7.11.30); KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX; HET: ANP; 2.08A {Homo sapiens} |
411 | 5DMZ_A | 365 | 252 | 100.0 | 2.2E-32 | [------------ ] | Mitotic checkpoint serine/threonine-protein kinase BUB1; kinase, phosphorylation, transferase; HET: SEP, ADP; 2.4A {Homo sapiens} |
412 | 4IJP_B | 358 | 243 | 100.0 | 3.2E-32 | [----------- ] | Serine/threonine-protein kinase PRP4 homolog (E.C.2.7.11.1); kinase, transferase, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: SO4, 1EH; 2.25A {Homo sapiens} |
413 | 3COI_A | 353 | 259 | 100.0 | 4.2E-32 | [------------ ] | Mitogen-activated protein kinase 13 (E.C.2.7.11.24); Kinase, p38d, p38delta, ERK, MAP; 2.09A {Homo sapiens} |
414 | 4U3Y_B | 332 | 241 | 100.0 | 2.6E-32 | [----------- ] | MAP4K4 (E.C.2.7.11.1); kinase, TRANSFERASE; 1.45A {Homo sapiens} |
415 | 3G2F_A | 336 | 259 | 100.0 | 1.4E-32 | [------------ ] | Bone morphogenetic protein receptor type-2; kinase, Structural Genomics, Structural Genomics; HET: SO4, EDO, ADP; 2.35A {Homo sapiens} |
416 | 5HES_B | 307 | 239 | 100.0 | 2.6E-33 | [------------ ] | Mitogen-activated protein kinase kinase kinase; Kinase, Complex, transferase; HET: TPO, 032; 2.14A {Homo sapiens} |
417 | 3ALN_B | 327 | 245 | 100.0 | 2.4E-32 | [----------- ] | Dual specificity mitogen-activated protein kinase; KINASE, PROTEIN AMP-PNP COMPLEX, TRANSFERASE; HET: ANP; 2.3A {Homo sapiens} |
418 | 3NIZ_A | 311 | 243 | 100.0 | 1E-31 | [----------- ] | Rhodanese family protein; Structural Genomics, Structural Genomics Consortium; HET: ADP; 2.4A {Cryptosporidium parvum} |
419 | 4JX3_A | 326 | 236 | 100.0 | 9.9E-33 | [----------- ] | Serine/threonine-protein kinase pim-1 (E.C.2.7.11.1); Human protein kinases, Serine/threonine-protein kinase; 2.5A {Homo sapiens} |
420 | 2W1Z_A | 368 | 236 | 100.0 | 4.5E-34 | [----------- ] | ROP2 (E.C.2.7.-.-); INACTIVITY, PROTEIN-KINASE, MEMBRANE-ATTACHMENT, TRANSFERASE; HET: SO4; 1.97A {TOXOPLASMA GONDII} |
421 | 4YLL_A | 361 | 194 | 100.0 | 3.4E-32 | [--------- ] | Dual specificity tyrosine-phosphorylation-regulated kinase 1A; halogen, inhibitor, Structural Genomics, Structural; HET: 4E3, PTR, SO4, EDO; 1.4A {Homo sapiens} |
422 | 2B9I_A | 353 | 286 | 100.0 | 1.7E-31 | [------------- ] | Mitogen-activated protein kinase FUS3 (E.C.2.7.1.37); TRANSFERASE; HET: ADP; 2.5A {Saccharomyces cerevisiae} |
423 | 3MI9_A | 351 | 276 | 100.0 | 1.2E-31 | [------------- ] | Cell division protein kinase 9; P-TEFb, Tat, HIV-1, PROTEIN BINDING; 2.1A {Homo sapiens} |
424 | 2B9H_A | 353 | 286 | 100.0 | 1.8E-31 | [------------- ] | Mitogen-activated protein kinase FUS3 (E.C.2.7.1.37); TRANSFERASE; HET: ADP; 1.55A {Saccharomyces cerevisiae} |
425 | 3HKO_A | 345 | 250 | 100.0 | 3.9E-32 | [----------- ] | Calcium/calmodulin-dependent protein kinase with a; structural genomics, protist parasite, cryptosporidium; HET: ANP; 1.8A {Cryptosporidium parvum Iowa II} |
426 | 5EFQ_A | 347 | 258 | 100.0 | 1E-31 | [------------ ] | Cyclin-dependent kinase 13 (E.C.2.7.11.22,2.7.11.23), Cyclin-K; kinase, cyclin, ADP, transferase; HET: TPO, ADP; 2.0A {Homo sapiens} |
427 | 3EQI_A | 360 | 259 | 100.0 | 2E-32 | [------------ ] | Dual specificity mitogen-activated protein kinase; MEK1 KINASE, ATP-binding, Disease mutation; HET: ADP; 1.9A {Homo sapiens} |
428 | 4LG4_A | 299 | 240 | 100.0 | 9.6E-32 | [----------- ] | Serine/threonine-protein kinase 3 (E.C.2.7.11.1); Hippo, Mst autoactivation, dimerization, SIGNALING; HET: GOL; 2.42A {Homo sapiens} |
429 | 4IIR_A | 358 | 243 | 100.0 | 6.2E-32 | [----------- ] | Serine/threonine-protein kinase PRP4 homolog (E.C.2.7.11.1); kinase, TRANSFERASE; HET: ANP, SO4; 2.0A {Homo sapiens} |
430 | 5MY8_A | 383 | 245 | 100.0 | 2.7E-32 | [----------- ] | SRSF protein kinase 1,SRSF protein; Transferase, splicing kinase, inhibitor, Structural; HET: CIT, EDO, RXZ; 1.7A {Homo sapiens} |
431 | 4CXA_C | 340 | 264 | 100.0 | 1.1E-31 | [------------ ] | CYCLIN-DEPENDENT KINASE 12 (E.C.2.7.11.22), CYCLIN-K; TRANSFERASE, KINASE; HET: TPO, ANP; 3.15A {HOMO SAPIENS} |
432 | 3A99_A | 320 | 237 | 100.0 | 2E-32 | [----------- ] | Proto-oncogene serine/threonine-protein kinase pim-1 (E.C.2.7.11.1); Pim-1, p27Kip1, peptide drug, prostate; HET: ANP; 1.6A {Homo sapiens} |
433 | 3ALO_A | 327 | 245 | 100.0 | 9.7E-33 | [----------- ] | Dual specificity mitogen-activated protein kinase; KINASE, ALLOSTERIC BINDING, ACTIVATION HELIX; HET: ANP; 2.6A {Homo sapiens} |
434 | 5G6V_A | 324 | 257 | 100.0 | 7.2E-32 | [------------ ] | CYCLIN-DEPENDENT KINASE 16 (E.C.2.7.11.22); TRANSFERASE; HET: 919, EDO; 2.2A {HOMO SAPIENS} |
435 | 4YU2_A | 361 | 193 | 100.0 | 6.5E-32 | [--------- ] | Dual specificity tyrosine-phosphorylation-regulated kinase 1A; TRANSFERASE, DYRK1A, down syndrome, inhibitor; HET: PTR, 4H5, PG4, SO4; 2.9A {Homo sapiens} |
436 | 4H36_A | 356 | 241 | 100.0 | 3.3E-32 | [----------- ] | Mitogen-activated protein kinase 10 (E.C.2.7.11.24); kinase, TRANSFERASE; 3.0A {Homo sapiens} |
437 | 2PZY_C | 324 | 258 | 100.0 | 1.2E-31 | [------------ ] | MAP kinase-activated protein kinase 2; MK2, Protein Kinase, TRANSFERASE; HET: B18, STU; 2.9A {Homo sapiens} |
438 | 3VVH_B | 341 | 254 | 100.0 | 3.4E-32 | [------------ ] | Dual specificity mitogen-activated protein kinase; kinase domain, kinase, TRANSFERASE-TRANSFERASE INHIBITOR; HET: ATP, 4BM; 2.0A {Homo sapiens} |
439 | 4M69_A | 313 | 255 | 100.0 | 6.9E-33 | [------------ ] | Receptor-interacting serine/threonine-protein kinase 3 (E.C.2.7.11.1); kinase, phosphorylation, TRANSFERASE-SIGNALING PROTEIN complex; HET: ANP, SO4; 2.497A {Mus musculus} |
440 | 1Q8Y_B | 373 | 264 | 100.0 | 9.2E-32 | [------------ ] | SR protein kinase (E.C.2.7.1.-); protein kinase, TRANSFERASE; HET: ADP, ADE, SO4; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 |
441 | 3SOC_B | 322 | 249 | 100.0 | 4.6E-32 | [------------ ] | Activin receptor type-2A (E.C.2.7.11.30); Structural Genomics Consortium, SGC, TRANSFERASE; HET: EDO, GVD; 1.95A {Homo sapiens} |
442 | 3KMU_A | 271 | 243 | 100.0 | 1.3E-31 | [------------ ] | Integrin-linked kinase, Alpha-parvin; CELL ADHESION, ANK repeat, ATP-binding; 1.8A {Homo sapiens} |
443 | 4F9C_A | 361 | 247 | 100.0 | 4.6E-32 | [----------- ] | Cell division cycle 7-related protein; SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION; HET: 0SX; 2.08A {Homo sapiens} |
444 | 3W8Q_A | 350 | 256 | 100.0 | 4.4E-32 | [------------ ] | Dual specificity mitogen-activated protein kinase; TRANSFERASE, Nucleotide-binding, Phosphorylation; HET: AGS; 2.2A {Homo sapiens} |
445 | 4F9B_A | 361 | 247 | 100.0 | 4.6E-32 | [----------- ] | Cell division cycle 7-related protein; SER/THR PROTEIN KINASE, TRANSFERASE, PHOSPHORYLATION; HET: 0SY; 2.5A {Homo sapiens} |
446 | 3C4Z_A | 543 | 254 | 100.0 | 4.2E-32 | [------------ ] | Rhodopsin kinase (E.C.2.7.11.14); Ser/Thr kinase, RGS homology domain; HET: ADP; 1.84A {Bos taurus} |
447 | 4JRN_A | 372 | 232 | 100.0 | 4.9E-33 | [----------- ] | Rhoptry kinase family protein; protein kinase, kinase, membrane, TRANSFERASE; HET: SUC, ANP; 2.71A {Toxoplasma gondii} |
448 | 3WAR_A | 340 | 239 | 100.0 | 5.4E-32 | [----------- ] | Casein kinase II subunit alpha; protein kinase, TRANSFERASE; HET: EDO; 1.04A {Homo sapiens} |
449 | 3EQC_A | 360 | 259 | 100.0 | 4.5E-32 | [------------ ] | Dual specificity mitogen-activated protein kinase; MEK1 KINASE, ATP-binding, Disease mutation; HET: 3BM, AGS; 1.8A {Homo sapiens} |
450 | 4E7W_A | 394 | 247 | 100.0 | 3E-31 | [------------ ] | Glycogen Synthase Kinase 3 (E.C.2.7.11.1); GSK3, Kinase, pTyr195, TRANSFERASE; 3.3A {Ustilago maydis} |
451 | 4L9I_A | 504 | 249 | 100.0 | 3.8E-32 | [------------ ] | Rhodopsin kinase (E.C.2.7.11.14); AGC family kinase, SER/THR KINASE; HET: 8PR, MES; 2.32A {Bos taurus} |
452 | 3OY1_A | 362 | 270 | 100.0 | 4.4E-32 | [------------- ] | Mitogen-activated protein kinase 10 (E.C.2.7.11.24); Kinase inhibitor, CNS, Selectivity, TRANSFERASE; HET: 589; 1.7A {Homo sapiens} |
453 | 1Q99_B | 373 | 264 | 100.0 | 9.2E-32 | [------------ ] | SR protein kinsae (E.C.2.7.1.-); protein kinase, TRANSFERASE; HET: ANP, SO4; 2.11A {Saccharomyces cerevisiae} SCOP: d.144.1.7 |
454 | 3KMW_A | 271 | 243 | 100.0 | 1.9E-31 | [------------ ] | Integrin-linked kinase, Alpha-parvin; CELL ADHESION, ANK repeat, ATP-binding; HET: ATP; 2.0A {Homo sapiens} |
455 | 5MOT_A | 328 | 238 | 100.0 | 3E-32 | [----------- ] | Casein kinase II subunit alpha; CK2alpha, CK2a, fragment based drug; HET: HBD, ACT; 2.09A {Homo sapiens} |
456 | 2PMO_X | 348 | 252 | 100.0 | 7.4E-33 | [------------ ] | Ser/Thr protein kinase, putative; Ser/Thr protein kinase Plasmodium; HET: HMD; 2.9A {Plasmodium falciparum} |
457 | 3FHR_A | 336 | 246 | 100.0 | 1.1E-31 | [------------ ] | MAP kinase-activated protein kinase 3; Kinase-inhibitor complex, ATP-binding, Kinase, Nucleotide-binding; HET: P4O; 1.9A {Homo sapiens} |
458 | 3E3P_B | 360 | 254 | 100.0 | 2E-31 | [------------ ] | Protein kinase, putative Glycogen synthase; glycogen synthase kinase, leishmaniasis, Kinase; 2.0A {Leishmania major} |
459 | 4ASX_A | 322 | 249 | 100.0 | 1.2E-31 | [------------ ] | ACTIVIN RECEPTOR TYPE-2A (E.C.2.7.11.30); TRANSFERASE, PROTEIN KINASE; HET: EDO, 6OJ; 2.05A {HOMO SAPIENS} |
460 | 5UV4_A | 311 | 252 | 100.0 | 7.7E-32 | [------------ ] | Putative leucine-rich repeat protein kinase; receptor-like kinase, leucine-rich repeat, sucrose-induced; HET: ANP; 2.3A {Zea mays} |
461 | 3PFQ_A | 674 | 239 | 100.0 | 1.7E-31 | [----------- ] | Protein kinase C beta type; Kinase, Phosphorylation, TRANSFERASE; HET: ANP; 4.0A {Rattus norvegicus} |
462 | 2PML_X | 348 | 253 | 100.0 | 2.3E-32 | [------------ ] | Ser/Thr protein kinase; Ser/Thr protein kinase Plasmodium; HET: ANP; 2.6A {Plasmodium falciparum} |
463 | 5XS2_A | 380 | 268 | 100.0 | 3.6E-31 | [------------ ] | Cyclin-dependent kinase 8 (E.C.2.7.11.22,2.7.11.23), Cyclin-C; CDK8, CYCLIN C, MEDIATOR COMPLEX; HET: 8D6; 2.04A {Homo sapiens} |
464 | 4YNO_A | 371 | 258 | 100.0 | 1E-30 | [------------ ] | MITOGEN-ACTIVATED PROTEIN KINASE 13 (E.C.2.7.11.24); P38 KINASE, TRANSFERASE; 1.7A {Homo sapiens} |
465 | 4L53_A | 307 | 240 | 100.0 | 1.3E-30 | [------------ ] | Mitogen-activated protein kinase kinase kinase; TAK1 kinase, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: 1UO; 2.55A {Homo sapiens} |
466 | 1H8F_A | 352 | 239 | 100.0 | 9.7E-31 | [----------- ] | GLYCOGEN SYNTHASE KINASE-3 BETA (E.C.2.7.1.37); KINASE, INSULIN PATHWAY; HET: EPE; 2.8A {HOMO SAPIENS} SCOP: d.144.1.7 |
467 | 2W99_B | 306 | 249 | 100.0 | 1.8E-31 | [------------ ] | G1/S-SPECIFIC CYCLIN-D1, CELL DIVISION PROTEIN; SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, TRANSFERASE, CELL; 2.8A {HOMO SAPIENS} |
468 | 3HDM_A | 373 | 239 | 100.0 | 6.6E-31 | [----------- ] | Serine/threonine-protein kinase Sgk1 (E.C.2.7.11.1); AGC PROTEIN KINASE, APOPTOSIS, ATP-BINDING; HET: MMG; 2.6A {Homo sapiens} |
469 | 3NYO_A | 576 | 238 | 100.0 | 4.3E-31 | [----------- ] | G protein-coupled receptor kinase 6; Kinase, GRK, RGS homology domain; HET: BU3, AMP, SO4; 2.92A {Homo sapiens} |
470 | 4EL9_A | 305 | 239 | 100.0 | 7.2E-32 | [----------- ] | Ribosomal protein S6 kinase alpha-3; serine/threonine kinase, TRANSFERASE-TRANSFERASE INHIBITOR complex; HET: AFE; 1.55A {Mus musculus} |
471 | 2R5T_A | 373 | 239 | 100.0 | 6.6E-31 | [----------- ] | Serine/threonine-protein kinase Sgk1 (E.C.2.7.11.1); AGC Protein Kinase, Apoptosis, ATP-binding; HET: ANP; 1.9A {Homo sapiens} |
472 | 3NPC_A | 364 | 257 | 100.0 | 3.1E-31 | [------------ ] | Mitogen-activated protein kinase 9 (E.C.2.7.11.24); DFG-out, Protein kinase, Transferase, ATP; HET: B96; 2.35A {Homo sapiens} |
473 | 4NM5_A | 377 | 240 | 100.0 | 5.7E-31 | [----------- ] | GSK3B protein (E.C.2.7.11.26), AXIN, Phosphorylated; Wnt, LRP6, Auto-inhibited, GSK-3, Axin; HET: GOL, ADP; 2.3A {Homo sapiens} |
474 | 5HNV_A | 302 | 240 | 100.0 | 2.4E-31 | [----------- ] | PpkA N terminal; Kinase, complex, t6ss, TRANSFERASE; HET: ATP; 1.41A {Serratia sp. FS14} |
475 | 4JR7_A | 374 | 248 | 100.0 | 2.9E-30 | [------------ ] | Casein kinase II subunit alpha; protein kinase, protein phosphorylation, TRANSFERASE; HET: GNP; 1.48A {Saccharomyces cerevisiae} |
476 | 4FI1_A | 374 | 247 | 100.0 | 1.4E-30 | [------------ ] | Casein kinase II subunit alpha; protein-ATP complex, protein kinase, Phosphorylation; HET: ATP, SO4; 2.09A {Saccharomyces cerevisiae} |
477 | 3OTV_C | 285 | 226 | 100.0 | 6.1E-31 | [------------ ] | PROBABLE CONSERVED TRANSMEMBRANE PROTEIN; peptidoglycan, Ser/Thr kinase, pseudokinase, Regulation; 3.094A {Mycobacterium tuberculosis} |
478 | 4C0T_A | 974 | 249 | 100.0 | 1.8E-30 | [----------- ] | LIKELY PROTEIN KINASE (E.C.2.7.11.1); TRANSFERASE, PDK1 ORTHOLOG; 3.16A {CANDIDA ALBICANS} |
479 | 4BF2_B | 334 | 249 | 100.0 | 9.5E-31 | [------------ ] | MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE; TRANSFERASE; HET: STU; 2.11A {HOMO SAPIENS} |
480 | 5GZA_A | 290 | 227 | 100.0 | 7.6E-31 | [------------ ] | Protein O-mannose kinase (E.C.2.7.1.183); protein O-mannose kinase, TRANSFERASE; HET: ZZ1, NAG, ADP, NGA, MAN; 2.0A {Danio rerio} |
481 | 3UQC_B | 286 | 227 | 100.0 | 2.5E-30 | [------------ ] | Intracellular Kinase Homology Domain of; Structural Genomics, TB Structural Genomics; 2.256A {Mycobacterium tuberculosis} |
482 | 2PZI_A | 681 | 226 | 100.0 | 6.5E-31 | [----------- ] | Probable serine/threonine-protein kinase pknG (E.C.2.7.11.1); Serine/Threonine-Protein Kinase, ATP-recognition, Kinase-inhibitor complex; HET: GOL, AXX; 2.4A {Mycobacterium tuberculosis} |
483 | 5UU1_A | 324 | 256 | 100.0 | 4.5E-31 | [----------- ] | BMP-2-inducible protein kinase (E.C.2.7.11.1); transferase, protein kinase domain, Structural; HET: 7DZ; 2.0A {Homo sapiens} |
484 | 3UBD_A | 304 | 237 | 100.0 | 3.3E-31 | [----------- ] | Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced fit, TRANSFERASE-TRANSFERASE; HET: SL0; 1.53A {Mus musculus} |
485 | 2PZI_B | 681 | 226 | 100.0 | 7.2E-31 | [----------- ] | Probable serine/threonine-protein kinase pknG (E.C.2.7.11.1); Serine/Threonine-Protein Kinase, ATP-recognition, Kinase-inhibitor complex; HET: GOL, AXX; 2.4A {Mycobacterium tuberculosis} |
486 | 2V62_A | 345 | 260 | 100.0 | 1.8E-30 | [------------ ] | SERINE/THREONINE-PROTEIN KINASE VRK2 (E.C.2.7.11.1); TRANSFERASE, ATP-BINDING, MEMBRANE, NUCLEOTIDE-BINDING, TRANSMEMBRANE; HET: EDO; 1.7A {HOMO SAPIENS} |
487 | 5K5N_B | 370 | 249 | 100.0 | 7.9E-30 | [------------ ] | Glycogen synthase kinase-3 beta (E.C.2.7.11.26,2.7.11.1); Protein kinase, Alzhimer's disease, tau; HET: PTR, 6QH, SO4; 2.2A {Homo sapiens} |
488 | 5GZ9_A | 305 | 227 | 100.0 | 2.7E-30 | [------------ ] | Protein O-mannose kinase (E.C.2.7.1.-); Sugar Kinase, Dystroglycanopathy, O-mannosylation, TRANSFERASE; HET: ANP, MAN; 2.4A {Mus musculus} |
489 | 5CKW_A | 451 | 224 | 100.0 | 6.2E-30 | [----------- ] | LegK4; Legionella, Bacterial effectors, serine/threonine kinase; HET: ANP; 2.49A {Legionella pneumophila (strain Lens)} |
490 | 5CKW_B | 451 | 224 | 100.0 | 8E-30 | [----------- ] | LegK4; Legionella, Bacterial effectors, serine/threonine kinase; HET: ANP; 2.49A {Legionella pneumophila (strain Lens)} |
491 | 5EBZ_J | 655 | 255 | 100.0 | 2.1E-29 | [------------ ] | Inhibitor of nuclear factor kappa-B; kinase, inhibitor, Transferase-transferase inhibitor complex; HET: GLC, 5TJ, 5LS, 5TM, Z4K, PDX, 5TH, 5TK, 5TL; 4.5A {Homo sapiens} |
492 | 4BWX_B | 429 | 214 | 100.0 | 2E-29 | [----------- ] | PAB-DEPENDENT POLY(A)-SPECIFIC RIBONUCLEASE SUBUNIT PAN-3; GENE REGULATION, DEADENYLASE, PAN2, MIRNA; HET: AGS; 2.85A {NEUROSPORA CRASSA} |
493 | 3V5W_A | 689 | 237 | 100.0 | 7.3E-29 | [----------- ] | G-protein coupled receptor kinase 2; Inhibitor complex, Protein kinase, Beta; HET: 8PR; 2.07A {Homo sapiens} |
494 | 4Q8J_H | 465 | 237 | 100.0 | 1.5E-30 | [----------- ] | PAB-dependent poly(A)-specific ribonuclease subunit PAN2; Ubiquitin carboxyl-terminal hydrolase-like domain, UCH; 3.796A {Saccharomyces cerevisiae} |
495 | 4CZY_B | 429 | 216 | 100.0 | 2.1E-29 | [----------- ] | PAB-DEPENDENT POLY(A)-SPECIFIC RIBONUCLEASE SUBUNIT PAN2; GENE REGULATION, WD40 DOMAIN, PSEUDOKINASE; HET: MES, ANP; 3.4A {NEUROSPORA CRASSA} |
496 | 4XR7_C | 465 | 237 | 100.0 | 1.5E-30 | [----------- ] | PAB-dependent poly(A)-specific ribonuclease subunit PAN2; RNA degradation, Deadenylation, Hydrolase, Pseudokinase; 3.796A {Saccharomyces cerevisiae} |
497 | 3KGA_A | 299 | 231 | 99.9 | 1.8E-28 | [------------ ] | MAP kinase-activated protein kinase 2; Small molecule inhibitor, 3-aminopyrazole scaffold; HET: LX9; 2.55A {Homo sapiens} |
498 | 3M2W_A | 299 | 227 | 99.9 | 2.4E-28 | [------------ ] | MAP kinase-activated protein kinase 2; SMALL MOLECULE INHIBITOR, spiroazetidine-tetracycle, ATP-SITE; HET: L8I; 2.41A {Homo sapiens} |
499 | 4KIK_B | 677 | 252 | 99.9 | 3.3E-28 | [------------ ] | Inhibitor of nuclear factor kappa-B; kinase, NkB signaling, TRANSFERASE; HET: KSA; 2.83A {Homo sapiens} |
500 | 5UGE_B | 364 | 263 | 99.9 | 2.2E-28 | [------------ ] | BMP-2-inducible protein kinase (E.C.2.7.11.1); transferase, protein kinase domain, Structural; HET: 584, PO4; 1.8A {Homo sapiens} |